EOS Med Chem Impurity Stock 20201029-52

   

EOS Med Chem is serving more than 100 Pharma companies, we have the original Drug Discovery Compounds, Like Impurity, small molecule and inhibitor.

Impurity we keep stock more than 80000, most in stock, we are World Sole Original Supplier, Each impurity we could supply: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA.

EOS Med Chem Quotation include: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, COA, MSDS.

Welcome to visit: our youtube:  https://youtu.be/r5cJdXKNXHk 

Contact:

EOS Med Chem, Medicinal Chemical is Big

執大象，天下往，往而無害，安平泰

Ms Nina

Youtube: https://youtu.be/r5cJdXKNXHk 

E: info@eosmedchem.com 

W: www.eosmedchem.com 

Tel: 0086-531-69905422

SALE OFFICE: 16F, China Overseas Plaza, Jinan City, China

4-Bromo-2-chlorobenzamide, CAS: 426265-73-8, stock: 2.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅BrClNO.

4-Bromo-2-ethoxybenzamide, CAS: 1228957-09-2, stock: 1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀BrNO₂.

4-Bromo-2-fluoro-6-methyl-benzamide, CAS: 1242156-51-9, stock: 2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇NOFBr.

4-Bromo-2-fluoro-N,N-dimethylbenzamide, CAS: 749927-80-8, stock: 5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrFNO.

4-Bromo-2-fluoro-N-isopropylbenzamide, CAS: 877383-76-1, stock: 4.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁BrFNO.

4-Bromo-2-fluoro-N-methylbenzamide, CAS: 749927-69-3, stock: 9.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇BrFNO.

4-Bromo-2-fluoro-N-methylbenzamide-d3, CAS: /, stock: 3.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄D₃BrFNO.

4-bromo-2-fluoro-N-[2-(pyrrolidin-1-yl)ethyl]benzamide, CAS: 1307443-30-6, stock: 4.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂OFBr.

4-Bromo-2-fluorobenzamide, CAS: 292621-45-5, stock: 2.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅BrFNO.

4-Bromo-2-hydroxy-N,N-dimethylbenzamide, CAS: 1243288-05-2, stock: 7.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀NO₂Br.

4-Bromo-2-methoxy-N,N-dimethylbenzamide, CAS: 1369774-49-1, stock: 7.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂BrNO₂.

4-Bromo-2-methoxy-N-propylbenzamide, CAS: 1393442-32-4, stock: 3.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄BrNO₂.

4-Bromo-2-methoxybenzamide, CAS: 812667-44-0, stock: 4.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈BrNO₂.

4-Bromo-2-propoxybenzamide, CAS: 1228957-02-5, stock: 2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂BrNO₂.

4-Bromo-3,5-dimethylbenzamide, CAS: 864825-81-0, stock: 6.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀BrNO.

4-Bromo-3-(trifluoromethyl)benzamide, CAS: 1034690-74-8, stock: 6.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅NOF₃Br.

4-bromo-3-chloro-N,N-dimethylbenzamide, CAS: 1369900-22-0, stock: 8.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NOClBr.

4-Bromo-3-chlorobenzamide, CAS: 1228826-41-2, stock: 9.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅BrClNO.

4-Bromo-3-fluoro-N-methylbenzamide, CAS: 865111-72-4, stock: 4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇BrFNO.

4-Bromo-3-fluorobenzamide, CAS: 759427-20-8, stock: 7.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅BrFNO.

4-Bromo-3-methoxybenzamide, CAS: 176961-57-2, stock: 4.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈BrNO₂.

4-Bromo-3-methylbenzamide, CAS: 170229-98-8, stock: 6.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈BrNO.

4-Bromo-3-nitrobenzamide, CAS: 879-93-6, stock: 7.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅BrN₂O₃.

4-Bromo-5-chloro-2-nitrobenzamide, CAS: 1629270-60-5, stock: 4.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄BrClN₂O₃.

4-Bromo-N,N-diethyl-2-fluorobenzamide, CAS: 682778-07-0, stock: 7.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃BrFNO.

4-Bromo-N,N-diethyl-2-methoxybenzamide, CAS: 1393442-26-6, stock: 2.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆BrNO₂.

4-bromo-N-(2-chloroethyl)benzamide, CAS: 1194057-63-0, stock: 3.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NOClBr.

4-bromo-N-(2-ethoxyethyl)benzamide, CAS: 1156088-43-5, stock: 6.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄NO₂Br.

4-Bromo-N-(2-hydroxyethyl)-3-methylbenzamide, CAS: 157672-18-9, stock: 5.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂BrNO₂.

4-Bromo-N-(2-methylphenyl)benzamide, CAS: 106736-05-4, stock: 7.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂NOBr.

4-Bromo-N-(4-bromophenyl)-3-[[(phenylmethyl)amino]sulfonyl]benzamide, CAS: 312756-74-4, stock: 8.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆Br₂N₂O₃S.

4-bromo-N-(4-methoxy-2-methylphenyl)benzamide, CAS: 1354953-14-2, stock: 6.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄NO₂Br.

4-Bromo-N-(5-chloro-2-pyridyl)benzamide, CAS: 300670-29-5, stock: 8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈N₂OClBr.

4-Bromo-N-(pyrazin-2-yl)benzamide, CAS: 1154240-14-8, stock: 2.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈N₃OBr.

4-Bromo-N-butyl-3-methylbenzamide, CAS: 1065073-96-2, stock: 3.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆BrNO.

4-Bromo-N-cyclopropyl-2-fluorobenzamide, CAS: 877383-84-1, stock: 3.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉BrFNO.

4-bromo-N-ethyl-2-hydroxy-N-methylbenzamide, CAS: 1250229-89-0, stock: 5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂NO₂Br.

4-Bromo-N-ethyl-3-fluorobenzamide, CAS: 1251351-08-2, stock: 4.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrFNO.

4-Bromo-N-methoxy-N-methylbenzamide, CAS: 192436-83-2, stock: 3.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀NO₂Br.

4-Bromo-N-propylbenzamide, CAS: 223557-19-5, stock: 7.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂NOBr.

4-bromo-N-pyridin-2-ylbenzamide, CAS: 14547-83-2, stock: 4.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉N₂OBr.

4-Bromo-N-t-butyl-2-fluorobenzamide, CAS: 303084-21-1, stock: 7.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃BrFNO.

4-Bromo-N-tert-butyl-2-chlorobenzamide, CAS: 1458481-93-0, stock: 3.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃BrClNO.

4-Bromobenzamide, CAS: 698-67-9, stock: 3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆BrNO.

4-Bromothiobenzamide, CAS: 26197-93-3, stock: 7.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆BrNS.

4-Butoxybenzamide, CAS: 73258-87-4, stock: 1.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₂.

4-Butylthiobenzamide, CAS: 1208077-46-6, stock: 6.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NS.

4-Carbamimidoylbenzamide hydrochloride, CAS: 59855-11-7, stock: 5.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₃O • HCl.

4-Chloro-2-fluoro-N-methylbenzamide, CAS: 1343038-33-4, stock: 3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇ClFNO.

4-Chloro-2-nitrobenzamide, CAS: 41994-91-6, stock: 7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅ClN₂O₃.

4-Chloro-3,5-dinitrobenzamide, CAS: 20731-63-9, stock: 6.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄N₃O₅Cl.

4-Chloro-3,5-dinitrobenzamide-15N2, CAS: /, stock: 9.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄ClN¹⁵N₂O₅.

4-Chloro-3-fluoro-benzenecarbothioamide, CAS: 177561-52-3, stock: 9.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅ClFNS.

4-Chloro-3-nitrobenzamide Oxime, CAS: 96898-75-8, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆N₃O₃Cl.

4-Chloro-N,N-diisopropylbenzamide, CAS: 79606-45-4, stock: 6.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈ClNO.

4-Chloro-N-(2-chloroethyl)benzamide, CAS: 51847-02-0, stock: 8.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉Cl₂NO.

4-Chloro-N-cyclopropyl-3-nitrobenzamide, CAS: 90797-58-3, stock: 6.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉ClN₂O₃.

4-Chloro-N-[2-(4-hydroxyphenyl)ethyl]benzamide, CAS: 41859-57-8, stock: 3.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄ClNO₂.

4-Chloro-N-[2-(4-hydroxyphenyl)ethyl]benzamide-d4, CAS: 1189464-84-3, stock: 5.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀D₄ClNO₂.

4-Chloro-N-[2-[[5-(trifluoromethyl)-2-pyridinyl]sulfonyl]ethyl]benzamide, CAS: 188591-46-0, stock: 4.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂ClF₃N₂O₃S.

4-Chlorobenzamide, CAS: 619-56-7, stock: 3.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆NOCl.

4-Chlorothiobenzamide, CAS: 2521-24-6, stock: 9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆ClNS.

4-Cyano-4-(4-fluorophenyl)cyclohexanone, CAS: 56326-98-8, stock: 2.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂FNO.

4-Cyano-N,N-dimethylbenzamide, CAS: 24167-50-8, stock: 4.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₂O.

4-Cyano-N-methoxy-N-methylbenzamide, CAS: 116332-64-0, stock: 5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₂O₂.

4-Cyano-N-methylbenzamide, CAS: 36268-62-9, stock: 7.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₂O.

4-Cyano-N-phenylbenzamide, CAS: 17922-96-2, stock: 5.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀N₂O.

4-Cyano-N-propylbenzamide, CAS: 855264-75-4, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂O.

4-Cyanobenzamide, CAS: 3034-34-2, stock: 8.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆N₂O.

4-Ethoxybenzamide, CAS: 55836-71-0, stock: 9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₂.

4-Ethoxythiobenzamide, CAS: 57774-79-5, stock: 7.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NOS.

4-Ethyl-2,3-dioxo-1-piperazinecarbonyl Chloride, CAS: 59703-00-3, stock: 1.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉ClN₂O₃.

4-Ethylbenzamide, CAS: 33695-58-8, stock: 3.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO.

4-Ethylthiobenzamide, CAS: 57774-76-2, stock: 3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NS.

4-Fluoro-2-(trifluoromethyl)benzamide, CAS: 207919-06-0, stock: 9.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅NOF₄.

4-Fluoro-2-methyl-thiobenzamide, CAS: 1256482-73-1, stock: 4.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈NFS.

4-Fluoro-2-nitrobenzamide, CAS: 106754-80-7, stock: 7.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅FN₂O₃.

4-Fluoro-3-(trifluoromethyl)benzamide, CAS: 67515-57-5, stock: 3.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅NOF₄.

4-Fluoro-3-methylbenzamide, CAS: 261945-92-0, stock: 5.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈FNO.

4-Fluoro-3-nitrobenzamide, CAS: 349-02-0, stock: 5.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅FN₂O₃.

4-Fluoro-N-(1,2,3,4-tetrahydroquinolin-5-yl)benzamide, CAS: 1016751-92-0, stock: 1.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅N₂OF.

4-Fluoro-N-(4-methoxybenzyl)benzamide, CAS: 346725-04-0, stock: 9.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄FNO₂.

4-Fluoro-n-methoxy-n-methylbenzamide, CAS: 116332-54-8, stock: 7.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀FNO₂.

4-Fluoro-N-methyl-3-nitrobenzamide, CAS: 475216-25-2, stock: 1.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇FN₂O₃.

4-Fluoro-N-methyl-N-[4-[6-[(1-methylethyl)amino]-4-pyrimidinyl]-2-thiazolyl]benzamide, CAS: 932737-65-0, stock: 6.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈FN₅OS.

4-Fluoro-N-methylbenzamide, CAS: 701-49-5, stock: 4.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈FNO.

4-Fluoro-N-{3-[1-(hydroxyimino)ethyl]phenyl}benzamide, CAS: 1016876-83-7, stock: 1.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃N₂O₂F.

4-Fluorobenzamide, CAS: 824-75-9, stock: 1.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆FNO.

4-Fluorobenzamide-D4, CAS: 1100750-65-9, stock: 2.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆FNO.

4-Fluorothiobenzamide, CAS: 22179-72-2, stock: 8.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆FNS.

4-Formyl-n-isopropylbenzamide, CAS: 13255-50-0, stock: 6.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₂.

4-Formyl-N-methylbenzamide, CAS: 167837-57-2, stock: 4.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₂.

4-Formyl-N-methylbenzamide-d3, CAS: /, stock: 9.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆D₃NO₂.

4-Hydroxy Flecainide, CAS: 152171-74-9, stock: 3.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀F₆N₂O₄.

4-Hydroxy Tolvaptan (Mixture of Diastereomers), CAS: 1587638-05-8, stock: 3.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₅ClN₂O₄.

4-Hydroxy-2-(trifluoromethyl)benzamide, CAS: 1208077-88-6, stock: 2.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆F₃NO₂.

4-Hydroxy-2-nitrobenzamide, CAS: 1261617-02-0, stock: 3.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆N₂O₄.

4-Hydroxy-N-(1,3,4-thiadiazol-2-yl)benzamide, CAS: 1019390-60-3, stock: 1.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇N₃O₂S.

4-Hydroxy-N-(1,3-thiazol-2-yl)benzamide, CAS: 94042-62-3, stock: 4.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈N₂O₂S.

4-Hydroxy-N-(2,2,2-trifluoroethyl)benzamide, CAS: 1019343-45-3, stock: 4.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈NO₂F₃.

4-Hydroxy-N-(2-hydroxyethyl)-N-methylbenzamide, CAS: 1183771-00-7, stock: 4.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₃.

4-Hydroxy-N-methylbenzamide, CAS: 27642-27-9, stock: 4.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.

4-hydroxy-N-phenylbenzamide, CAS: 14121-97-2, stock: 2.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁NO₂.

4-Hydroxy-N-propylbenzamide, CAS: 27519-68-2, stock: 5.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂.

4-Hydroxy-N-[(2S)-2-hydroxypropyl]benzamide, CAS: 1141930-90-6, stock: 8.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₃.

4-Hydroxybenzamide, CAS: 619-57-8, stock: 1.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₂.

4-Hydroxybenzamide Hydrate, CAS: 138169-57-0, stock: 3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₂ • H ₂O.

4-Hydroxythiobenzamide, CAS: 25984-63-8, stock: 5.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NOS.

4-IBP, CAS: 155798-08-6, stock: 3.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁IN₂O.

4-iodo-2-nitrobenzamide, CAS: 1261585-43-6, stock: 3.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅N₂O₃I.

4-Iodo-3,5-dimethyl-benzamide, CAS: 1206679-91-5, stock: 3.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀NOI.

4-iodo-N-(pyrazin-2-yl)benzamide, CAS: 1250516-70-1, stock: 1.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈N₃OI.

4-Iodo-N-isopropylbenzamide, CAS: 425416-87-1, stock: 2.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂INO.

4-Iodo-N-methylbenzamide, CAS: 89976-43-2, stock: 8.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈INO.

4-Iodo-N-propylbenzamide, CAS: 39887-30-4, stock: 7.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂INO.

4-Iodobenzamide, CAS: 08/07/3956, stock: 1.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆INO.

4-methanesulfonyl-N-methoxy-N-methylbenzamide, CAS: 1330905-10-6, stock: 1.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₄S.

4-Methanesulfonylbenzamide, CAS: 4461-38-5, stock: 5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₃S.

4-Methoxy-2-methyl-benzamide, CAS: 139583-91-8, stock: 8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₂.

4-Methoxy-2-nitrobenzamide, CAS: 33844-22-3, stock: 1.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈N₂O₄.

4-Methoxy-3-nitrobenzamide, CAS: 10397-58-7, stock: 1.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈N₂O₄.

4-Methoxy-N-(2-methylphenyl)benzamide, CAS: 7464-54-2, stock: 7.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO₂.

4-Methoxy-N-[2-(piperazin-1-yl)ethyl]benzamide Dihydrochloride, CAS: 1269152-40-0, stock: 5.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁N₃O₂.₂[HCl].

4-Methoxybenzamide, CAS: 3424-93-9, stock: 6.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.

4-Methoxybenzyl 5-bromo-2-chlorobenzamide, CAS: 701255-27-8, stock: 4.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃BrClNO₂.

4-Methoxythiobenzamide, CAS: 2362-64-3, stock: 7.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NOS.

4-Methyl-3-(trifluoromethyl)benzoic Acid, CAS: 261952-01-6, stock: 2.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇F₃O₂.

4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzamide, CAS: 851137-91-2, stock: 2.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅N₅O.

4-Methyl-N-(5-methyl-2-pyridinyl)benzamide, CAS: 349122-64-1, stock: 8.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄N₂O.

4-Methyl-N-(5-methyl-2-pyridinyl)benzamide-d6, CAS: 1330277-06-9, stock: 9.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈D₆N₂O.

4-Methyl-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide Methane Sulpfonate, CAS: /, stock: 2.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁N₅O • CH  ₄O₃S.

4-Methylbenzamide, CAS: 619-55-6, stock: 3.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO.

4-Nitrobenzamide, CAS: 619-80-7, stock: 4.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆N₂O₃.

4-Nitrothiobenzamide, CAS: 26060-30-0, stock: 7.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆N₂O₂S.

4-O-Des(difluoromethyl) Roflumilast, CAS: 475271-62-6, stock: 10g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄Cl₂N₂O₃.

4-Phenyl-2-thiazoleacetic Acid, CAS: 38107-10-7, stock: 1.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉NO₂S.

4-Phenyl-2-thiazoleacetic Acid-d5, CAS: /, stock: 5.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₄D₅NO₂S.

4-Sulfamoylbenzamide, CAS: 6306-24-7, stock: 8.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₃S.

4-tert-butyl-N-(4-hydroxyphenyl)benzamide, CAS: 129488-39-7, stock: 2.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NO₂.

4-tert-Butylbenzhydroxamic Acid, CAS: 62034-73-5, stock: 5.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₂.

4-Trifluoromethylbenzamide Oxime, CAS: 22179-86-8, stock: 8.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇F₃N₂O.

4-[(1,3-Dioxoisoindol-2-yl)methyl]benzamide, CAS: 790681-49-1, stock: 2.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂N₂O₃.

4-[(1-Cyano-1-methylethyl)amino]-N-methylbenzamide, CAS: /, stock: 7.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅N₃O.

4-[(2,6-Dimethylmorpholin-4-yl)sulfonyl]aniline, CAS: 750607-99-9, stock: 2.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O₃S.

4-[(2-Bromoacetyl)amino]-N-methylbenzamide, CAS: 1138443-67-0, stock: 7.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁N₂O₂Br.

4-[(2-hydroxyethyl)amino]-3-nitrobenzamide, CAS: 138377-66-9, stock: 3.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₃O₄.

4-[(3-methyl-2,5-dioxoimidazolidin-1-yl)methyl]-3-nitrobenzamide, CAS: 1258639-89-2, stock: 4.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂N₄O₅.

4-[(4-Amino-2-ethoxy-5-nitrobenzoyl)amino]-1-piperidinecarboxylic Acid Ethyl Ester, CAS: 952309-99-8, stock: 4.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄N₄O₆.

4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)-benzenamine, CAS: 630125-91-6, stock: 3.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀F₃N₃.

4-[(Butan-2-yl)amino]benzamide, CAS: 1019497-02-9, stock: 8.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O.

4-[(Chloroacetyl)amino]benzamide, CAS: 85126-67-6, stock: 3.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉ClN₂O₂.

4-[(Cyclopropylamino)methyl]-3-fluorobenzamide, CAS: 1016750-17-6, stock: 4.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₂OF.

4-[(Cyclopropylamino)methyl]-N-(2,2,2-trifluoroethyl)benzamide Hydrochloride, CAS: 1156895-98-5, stock: 7.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅N₂OF₃ • HCl.

4-[(Cyclopropylamino)methyl]benzamide Hydrochloride, CAS: 1172028-71-5, stock: 6.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O  •  HCl.

4-[(ethylamino)methyl]-N,N-dimethylbenzamide hydrochloride, CAS: 1258651-78-3, stock: 8.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O.HCl.

4-[(Methylamino)methyl]-N-(2,2,2-trifluoroethyl)benzamide Hydrochloride, CAS: 1156895-87-2, stock: 7.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₂OF₃ • HCl.

4-[({1-[(4-bromophenyl)methyl]piperidin-4-yl}carbamoyl)methoxy]benzamide, CAS: 1427986-92-2, stock: 2.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄N₃O₃Br.

4-[2-(2-Furanyl)-6-(4-nitrophenyl)-4-pyridinyl]benzamide, CAS: 581073-80-5, stock: 8.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₅N₃O₄.

4-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzene Sulfonamide, CAS: 16673-34-0, stock: 6.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇ClN₂O₄S.

4-[2-(Dimethylamino)ethoxy]benzylamine, CAS: 20059-73-8, stock: 7.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈N₂O.

4-[3-[4-(Aminoiminomethyl)phenyl]-1-triazenyl]benzamide, CAS: 150995-10-1, stock: 8.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄N₆O.

4-[3-[4-(Aminoiminomethyl)phenyl]-1-triazenyl]benzamide-13C ,15N2, CAS: /, stock: 6.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃¹³CH₁₄N₄¹⁵N₂O.

4-[4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]-benzamide, CAS: 301836-43-1, stock: 4.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₈N₄O₃.

4-[4-(Chloromethyl)-1,3-thiazol-2-yl]benzamide, CAS: 1094402-62-6, stock: 8.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉N₂OSCl.

4-[[2-[[4-Cyano-3-(trifluoromethyl)phenyl]amino]-1,1-dimethyl-2-oxoethyl]amino]-2-fluoro-N-methyl-benzamide, CAS: 1289942-55-7, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈F₄N₄O₂.

4-{[(2-Hydroxyphenyl)methyl]amino}benzamide, CAS: 1021124-73-1, stock: 2.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄N₂O₂.

4-{[(3-Fluorophenyl)amino]methyl}benzamide, CAS: 1020984-59-1, stock: 4.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃N₂OF.

4’-Aminobenzanilide, CAS: 17625-83-1, stock: 4.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂N₂O.

5,5’-(Piperazine-2,5-diyl)bis(2-hydroxybenzamide), CAS: /, stock: 1.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀N₄O₄.

5,6-Difluoro Anthranilic Acid, CAS: 442134-72-7, stock: 1.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅F₂NO₂.

5-(2,3-Dichlorobenzamido) Lamotrigine, CAS: /, stock: 8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₉Cl₄N₅O.

5-(2-(Benzylamino)-1-hydroxyethyl)-2-hydroxybenzamide, CAS: /, stock: 3.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₂O₃.

5-(2-Amino-1-hydroxyethyl)-2-hydroxy-benzamide Hydrochloride, CAS: 32780-65-7, stock: 7.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₃.

5-(2-Bromoacetyl)-2-(phenylmethoxy)benzamide, CAS: 72370-19-5, stock: 2.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄BrNO₃.

5-(Dimethylsulfamoyl)-N-(5-methyl-1,3-thiazol-2-yl)-2-(pyrrolidin-1-yl)benzamide, CAS: 790702-57-7, stock: 3.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂N₄O₃S₂.

5-Acetyl-2-(phenylmethoxy)benzamide, CAS: 75637-30-8, stock: 4.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NO₃.

5-Acetylsalicylamide, CAS: 40187-51-7, stock: 6.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₃.

5-Amino-1,4-dimethylimidazole Hydrochloride, CAS: 1427475-33-9, stock: 2.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉N₃ • HCl.

5-Amino-2-(2,2,2-trifluoroethoxy)benzamide, CAS: 1247057-55-1, stock: 5.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉N₂O₂F₃.

5-Amino-2-(dimethylamino)benzamide, CAS: 1226805-88-4, stock: 2.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₃O.

5-Amino-2-(propan-2-yloxy)benzamide, CAS: 1171179-05-7, stock: 8.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₂.

5-Amino-2-bromobenzamide, CAS: 220583-56-2, stock: 2.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇BrN₂O.

5-Amino-2-bromobenzamide Hydrochloride, CAS: 1211398-47-8, stock: 7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇N₂OBr  •  HCl.

5-Amino-2-chloro-N-(thiophen-2-ylmethyl)benzamide, CAS: 1099610-86-2, stock: 1.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁N₂OSCl.

5-Amino-2-chloro-N-ethyl-N-(propan-2-yl)benzamide, CAS: 1094910-07-2, stock: 6.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇N₂OCl.

5-Amino-2-chloro-N-methylbenzamide, CAS: 111362-49-3, stock: 9.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₂OCl.

5-Amino-2-chloro-N-methylbenzamide Hydrochloride, CAS: 1193389-36-4, stock: 2.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₂OCl  •  HCl.

5-Amino-2-chloro-N-phenylbenzamide, CAS: 111362-57-3, stock: 4.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁N₂OCl.

5-Amino-2-chlorobenzamide, CAS: 111362-50-6, stock: 9.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇N₂OCl.

5-Amino-2-fluoro-N-methylbenzamide, CAS: 1153287-97-8, stock: 9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₂OF.

5-Amino-2-fluoro-N-methylbenzamide Hydrochloride, CAS: 1242840-35-2, stock: 2.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₂OF  •  HCl.

5-Amino-2-fluorobenzamide, CAS: 518057-72-2, stock: 4.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇FN₂O.

5-Amino-2-methoxybenzamide, CAS: 22961-58-6, stock: 8.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂O₂.

5-amino-2-methyl-N-(propan-2-yl)benzamide, CAS: 1249670-98-1, stock: 5.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O.

5-amino-N,2-dimethyl-N-(propan-2-yl)benzamide, CAS: 1250353-98-0, stock: 4.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O.

5-amino-N,N,2-trimethylbenzamide, CAS: 130370-03-5, stock: 8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O.

5-Amino-N-(2H-1,3-benzodioxol-5-ylmethyl)-2-chlorobenzamide, CAS: 1018269-73-2, stock: 8.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃N₂O₃Cl.

5-Amino-N-benzyl-2-chloro-N-ethylbenzamide, CAS: 1018522-83-2, stock: 2.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₂OCl.

5-Aminopyridine-3-boronic Acid Hydrochloride, CAS: 1310384-34-9, stock: 5.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇BN₂O₂ • HCl.

5-​Methyl-​2-​nitroaniline, CAS: 578-46-1, stock: 3.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.

5-Bromo-2,3-difluoro-N-methoxy-N-methylbenzamide, CAS: 1600511-62-3, stock: 1.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈BrF₂NO₂.

5-Bromo-2-(trifluoromethyl)benzamide, CAS: 1548-16-9, stock: 4.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅BrF₃NO.

5-Bromo-2-chlorobenzamide, CAS: 188774-55-2, stock: 5.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅BrClNO.

5-Bromo-2-fluorobenzamide, CAS: 214210-17-0, stock: 4.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅NOFBr.

5-Bromo-2-methoxybenzamide, CAS: 303111-31-1, stock: 1.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈BrNO₂.

5-Bromo-2-nitrobenzamide, CAS: 89642-23-9, stock: 6.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅BrN₂O₃.

5-bromo-N,2-dimethylbenzamide, CAS: 1290634-39-7, stock: 1.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀NOBr.

5-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-2-methylbenzamide, CAS: 1403257-80-6, stock: 5.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀N₃O₃Br.

5-Bromoacetyl-2-hydroxybenzamide, CAS: 73866-23-6, stock: 6.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈BrNO₃.

5-Chloro-2-(trifluoromethyl)benzamide, CAS: 654-94-4, stock: 3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅NOF₃Cl.

5-Chloro-2-fluorobenzamide, CAS: 261762-57-6, stock: 3.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅NOFCl.

5-Chloro-2-methoxy-N-(2-phenylethyl)benzamide, CAS: 33924-49-1, stock: 3.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆ClNO₂.

5-chloro-2-methoxy-N-methyl-3-sulfamoylbenzamide, CAS: 1486433-08-2, stock: 5.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₂O₄SCl.

5-Chloro-2-methylbenzamide, CAS: 1028252-11-0, stock: 5.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈NOCl.

5-Chloro-2-nitroaniline, CAS: 1635-61-6, stock: 8.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅ClN₂O₂.

5-Chloro-2-nitrobenzamide, CAS: 40763-96-0, stock: 9.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅ClN₂O₃.

5-Chloro-N-(5-chloro-2-methoxybenzoyl)-N-(4-(N-(4-chloro-2-methoxybenzoyl)sulfamoyl)phenethyl)-2-methoxybenzamide, CAS: /, stock: 7.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₇Cl₃N₂O₈S.

5-Chloro-N-(5-methoxy-2-hydroxyphenyl)-2-fluoro-benzamide, CAS: 1797116-69-8, stock: 1.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁ClFNO₃.

5-Chloro-N-methyl-2-nitrobenzamide, CAS: 272108-86-8, stock: 6.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇ClN₂O₃.

5-Chloro-N-[4-[[2,3-dihydro-5-(methoxymethyl)-1-methyl-3-oxo-2-phenyl-1H-pyrazol-4-yl]amino]-2,2-dimethyl-4-oxobutyl]-2-ethoxy-4-fluoro-benzamide, CAS: 1805818-06-7, stock: 5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₂ClFN₄O₅.

5-Chloroacetylsalicylamide, CAS: 33254-88-5, stock: 1.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈ClNO₃.

5-Chloroisatoic Anhydride, CAS: 4743-17-3, stock: 7.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄ClNO₃.

5-Cyano-2-fluorobenzamide, CAS: 916213-61-1, stock: 3.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅FN₂O.

5-Dechloro Roflumilast, CAS: 1391053-75-0, stock: 5.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅ClF₂N₂O₃.

5-Dehydro Tolvaptan, CAS: 137973-76-3, stock: 1.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₃ClN₂O₃.

5-Dehydro Tolvaptan-d7, CAS: 1296212-29-7, stock: 2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₆D₇ClN₂O₃.

5-Ethoxy-2-nitrobenzamide, CAS: 1420800-21-0, stock: 7.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O₄.

5-Fluoro-2-nitrobenzamide, CAS: 77206-97-4, stock: 4.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅FN₂O₃.

5-Hydroxy Indapamide, CAS: 126750-70-7, stock: 8.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆ClN₃O₄S.

5-Hydroxy Indapamide Methyl Ether, CAS: 1391053-97-6, stock: 9.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈ClN₃O₄S.

5-Hydroxy Indapamide-13C,d3, CAS: /, stock: 4.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅¹³CH₁₃D₃ClN₃O₄S.

5-Hydroxy-2-methylbenzamide, CAS: 1243287-58-2, stock: 8.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.

5-Hydroxy-N-(pyridin-2-ylmethyl)-2-(2,2,2-trifluoroethoxy)benzamide, CAS: 83526-32-3, stock: 9.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃F₃N₂O₃.

5-Methoxy-2-nitrobenzamide, CAS: 41994-92-7, stock: 2.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈N₂O₄.

5-methyl-2-(pyrrolidin-1-yl)benzamide, CAS: 1306604-34-1, stock: 3.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O.

5-Nitroanthranilamide, CAS: 16313-65-8, stock: 1.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇N₃O₃.

5’-Oxo Amisulpride, CAS: 1391052-47-3, stock: 2.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅N₃O₅S.

6-Amino-5-(4-sulfonamidobenzoyl)-N-(methylamino)-1-methyluracil, CAS: 149981-39-5, stock: 3.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅N₅O₅S.

6-Chloro-2-fluoro-3-methylbenzamide, CAS: 286474-61-1, stock: 7.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇NOFCl.

6-Chloronicotinic Acid, CAS: 5326-23-8, stock: 7.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄ClNO₂.

6-Hydroxy-12,12a-seco-tigecyclin-12-oic Acid 6,12-Lactone, CAS: /, stock: 3.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₈N₄O₉.

6-Hydroxy-2-phenyl-pyrimidine-4-carboxylic Acid, CAS: 84659-98-3, stock: 3.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈N₂O₃.

6-Hydroxyindoramin Hydrochloride, CAS: 1797124-48-1, stock: 3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆ClN₃O₂.

6-Hydroxyindoramin-d5 Hydrochloride, CAS: /, stock: 4.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁D₅ClN₃O₂.

6-Methyl-4-hydroxypyrimidine, CAS: 3524-87-6, stock: 7.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₂O.

6-Morpholinonicotinaldehyde, CAS: 173282-60-5, stock: 9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₂.

7,8-Dihydro-4H-thieno[3,2-b]azepin-5(6H)-one, CAS: 4751-61-5, stock: 4.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NOS.

AAL-993, CAS: 269390-77-4, stock: 6.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆F₃N₃O.

ABT 199(Venetoclax), CAS: 1257044-40-8, stock: 4.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₅₀ClN₇O₇S.

ABT 199 (>99%)(Venetoclax), CAS: 1257044-40-8, stock: 1.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₅₀ClN₇O₇S.

ABT 263, CAS: 923564-51-6, stock: 3.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₅₅ClF₃N₅O₆S₃.

ABT 263-d8, CAS: 1217620-38-6, stock: 7.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₄₇D₈ClF₃N₅O₆S₃.

ABT 737, CAS: 852808-04-9, stock: 3.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₄₅ClN₆O₅S₂.

ABT 737-d8, CAS: 1217686-68-4, stock: 4.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₃₇D₈ClN₆O₅S₂.

Acalabrutinib, CAS: 1420477-60-6, stock: 2.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₃N₇O₂.

ACHN 975, CAS: 1410809-36-7, stock: 2.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃N₃O₄.

AL 8697, CAS: 1057394-06-5, stock: 2.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁F₃N₄O.

Alda 1, CAS: 349438-38-6, stock: 3.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁Cl₂NO₃.

Alibendol, CAS: 26750-81-2, stock: 8.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₄.

Alogliptin N-Formamide, CAS: /, stock: 5.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃N₅O₄.

Alogliptin Namino-[2-(2-hydroxyethylcarbamoyl)benzamide], CAS: /, stock: 6.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₁N₅O₅.

AMG-47a, CAS: 882663-88-9, stock: 7.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₈F₃N₅O₂.

Aminopotentidine, CAS: 140873-26-3, stock: 9.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₅N₇O₂.

Amisulpride, CAS: 71675-85-9, stock: 6.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₇N₃O₄S.

Amisulpride N-Oxide, CAS: 71676-01-2, stock: 2.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₇N₃O₅S.

Amisulpride-d5, CAS: 1216626-17-3, stock: 6.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂D₅N₃O₄S.

Amisulpride-d5 N-Oxide, CAS: 1794756-15-2, stock: 6.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂D₅N₃O₅S.

AMTB Hydrochloride, CAS: 926023-82-7, stock: 1.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆N₂O₂S • HCl.

Apoptozole, CAS: 1054543-47-3, stock: 5.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₅F₆N₃O₃.

AR-42, CAS: 935881-37-1, stock: 4.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀N₂O₃.

ARN 272, CAS: 488793-85-7, stock: 3.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₀N₄O₂.

Ataciguat, CAS: 254877-67-3, stock: 6.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉Cl₂N₃O₆S₃.

Axitinib, CAS: 319460-85-0, stock: 9.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈N₄OS.

Axitinib Dimer (Asymmetric Impurity), CAS: 1428728-84-0, stock: 7.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₃₆N₈O₂S₂.

Axitinib Galactose Adduct, CAS: /, stock: 9.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₈N₄O₆S.

Axitinib Sulfoxide, CAS: 1347304-18-0, stock: 8.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈N₄O₂S.

Axitinib-d3, CAS: 1126623-89-9, stock: 6.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₅D₃N₄OS.

AZ 12080282 Dihydrochloride, CAS: 1126367-99-4, stock: 7.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂Cl₂N₄O₂.

AZ 628, CAS: 878739-06-1, stock: 9.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₅N₅O₂.

AZ-628, CAS: 1026601-22-8, stock: 4.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₇N₅O₂.

AZD2014, CAS: 1009298-59-2, stock: 8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₀N₆O₃.

AZD2014-13C,d3, CAS: /, stock: 9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇D₃N₆O₃.

AZD4547, CAS: 1035270-39-3, stock: 1.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₃N₅O₃.

Bafetinib, CAS: 859212-16-1, stock: 1.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₁F₃N₈O.

Balicatib, CAS: 354813-19-7, stock: 8.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₃N₅O₂.

Bcr-abl Inhibitor, CAS: 778270-11-4, stock: 1.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₃F₃N₄O₂.

Bencarbazone, CAS: 173980-17-1, stock: 1.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃F₄N₅O₃S₂.

Benodanil, CAS: 15310-01-7, stock: 4.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀INO.

Benzamide, CAS: 55-21-0, stock: 7.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO.

Benzamide Oxime, CAS: 613-92-3, stock: 7.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O.

Benzamide-15N, CAS: 31656-62-9, stock: 6.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇¹⁵NO.

Benzamide-d5, CAS: 1235489-47-0, stock: 8.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₂D₅NO.

Benzohydroxamic Acid, CAS: 495-18-1, stock: 6.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₂.

Benzothiazole, CAS: 95-16-9, stock: 5.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅NS.

Benzothiazole-d4, CAS: 194423-51-3, stock: 8.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇HD₄NS.

Benzoyl Fentanyl-d5, CAS: /, stock: 7.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₃D₅N₂O.

Benzoyl-D-arginine 4-Nitroanilide Hydrochloride, CAS: 21653-41-8, stock: 8.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂N₆O₄•HCl.

Benzyl 5-bromo-2-chlorobenzamide, CAS: 892018-65-4, stock: 5.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁BrClNO.

Betrixaban, CAS: 330942-05-7, stock: 5.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂ClN₅O₃.

BI 2536, CAS: 755038-02-9, stock: 5.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₉N₇O₃.

Bistrifluron, CAS: 201593-84-2, stock: 2.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₇ClF₈N₂O₂.

BIX NHE1 Inhibitor, CAS: 1422252-46-7, stock: 8.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉F₃N₄O₂ •HCl.

BMS 509744, CAS: 439575-02-7, stock: 6.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₁N₅O₄S₂.

BMS 795311, CAS: 939390-99-5, stock: 6.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₃F₁₀NO₃.

BMS 833923, CAS: 1059734-66-5, stock: 9.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₇N₅O.

BMS CCR2 22, CAS: 445479-97-0, stock: 7.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₄F₃N₅O₄S.

Boc-(R)-3-amino-3-(4-bromophenyl)propionic Acid, CAS: 261380-20-5, stock: 3.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈NO₄Br.

BPR1J-097, CAS: 1327167-19-0, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₈N₆O₃S.

Bromo-N-(2-hydroxy-1,1-dimethylethyl)benzamide, CAS: 33708-69-9, stock: 3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄BrNO₂.

Bromopride, CAS: 4093-35-0, stock: 8.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂BrN₃O₂.

Bromopride-d3, CAS: 1189498-49-4, stock: 8.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉D₃BrN₃O₂.

Butyl 4-bromo-2-ethoxybenzamide, CAS: 1261895-85-5, stock: 2.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈BrNO₂.

Butyl 5-bromo-2-chlorobenzamide, CAS: 1184623-42-4, stock: 1.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃BrClNO.

Butylamine Hydrochloride, CAS: 3858-78-4, stock: 1.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₂ClN.

BW 373U86, CAS: 155836-50-3, stock: 5.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇N₃O₂.

Calhex 231, CAS: 652973-93-8, stock: 2.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇ClN₂O.

Cariporide, CAS: 159138-80-4, stock: 3.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇N₃O₃S.

CAY10626, CAS: 1202884-94-3, stock: 9.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₅F₃N₈O₃.

CCG-1423, CAS: 285986-88-1, stock: 9.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₃ClF₆N₂O₃.

CD73-IN-1, CAS: 2132396-40-6, stock: 6.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇N₃O₄S.

CDPPB, CAS: 781652-57-1, stock: 5.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₆N₄O.

CEP-37440, CAS: 1391712-60-9, stock: 6.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₈ClN₇O₃.

CGI 1746, CAS: 910232-84-7, stock: 3.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₇N₅O₄.

Chidamide, CAS: 743438-44-0, stock: 8.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉FN₄O₂.

Chlorfluazuron, CAS: 71422-67-8, stock: 6.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₉Cl₃F₅N₃O₃.

Chlorthiamid, CAS: 1918-13-4, stock: 2.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅Cl₂NS.

CID 1375606, CAS: 313493-80-0, stock: 5.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄Cl₂N₂O₂.

Cinitapride, CAS: 66564-14-5, stock: 7.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀N₄O₄.

Cinitapride Tartrate, CAS: 96623-56-2, stock: 8.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₆N₄O₁₀.

Cinitapride-d5, CAS: /, stock: 6.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅D₅N₄O₄.

cis-(+/-)-3,4-Dichloro-N-methyl-N-(2-[1-pyrrolidinyl]cyclohexyl)benzeneacetamide, CAS: 92953-41-8, stock: 6.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄Cl₂N₂O.

Cisapride, CAS: 81098-60-4, stock: 7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉ClFN₃O₄.

Cisapride Monohydrate, CAS: 260779-88-2, stock: 8.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉ClFN₃O₄ • H ₂O.

Cisapride N-Oxide, CAS: 86718-75-4, stock: 9.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉ClFN₃O₅.

Cisapride-13C,d3, CAS: 1285970-69-5, stock: 1.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂¹³CH₂₆D₃ClFN₃O₄.

Clopamide, CAS: 636-54-4, stock: 6.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀ClN₃O₃S.

Clopamide-d6, CAS: 1346602-07-0, stock: 5.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄D₆ClN₃O₃S.

Closantel, CAS: 57808-65-8, stock: 7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₄Cl₂I₂N₂O₂.

Closantel Dimer, CAS: /, stock: 9.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₂₇Cl₃I₄N₄O₄.

Closantel Sodium Salt, CAS: 61438-64-0, stock: 9.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₃Cl₂I₂N₂NaO₂.

Closantel-13C6, CAS: 1325559-20-3, stock: 8.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³C₆H₁₄Cl₂I₂N₂O₂.

CMPD101, CAS: 865608-11-3, stock: 4.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁F₃N₆O.

CPPHA, CAS: 693288-97-0, stock: 1.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₅ClN₂O₄.

CRT5, CAS: 1034297-58-9, stock: 6.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₀N₄O₂.

CW 008, CAS: 1134613-19-6, stock: 3.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₄F₂N₆O₂.

Cyclohexyl 4-bromo-2-ethoxybenzamide, CAS: 1261895-34-4, stock: 5.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀BrNO₂.

Cyclopropyl 5-bromo-2-chlorobenzamide, CAS: 669734-35-4, stock: 1.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉BrClNO.

CYT387, CAS: 1056634-68-4, stock: 3.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂N₆O₂.

Danusertib, CAS: 827318-97-8, stock: 8.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₀N₆O₃.

Darexaban Maleate, CAS: 365462-24-4, stock: 9.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₄N₄O₈.

Darexaban-d3 Maleate, CAS: 1346606-64-1, stock: 9.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₁D₃N₄O₈.

De-4-fluoro 5-Fluoro Chidamide, CAS: 743420-02-2, stock: 4.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉FN₄O₂.

De-5-fluoro 4-Fluorochidamide-d4, CAS: /, stock: 1.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₅D₄FN₄O₂.

DEET, CAS: 134-62-3, stock: 9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO.

DEET-d10, CAS: 1215576-01-4, stock: 5.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇D₁₀NO.

Defactinib, CAS: 1073154-85-4, stock: 1.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁F₃N₈O₃S.

Defluoro-MDV 3100 (Defluoro-enzalutamide), CAS: 915087-16-0, stock: 9.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₇F₃N₄O₂S.

Defluoro-MDV 3100-d3 (Defluoro-enzalutamide-d3), CAS: /, stock: 9.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₄D₃F₃N₄O₂S.

Dehydro Indapamide, CAS: 63968-75-2, stock: 3.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄ClN₃O₃S.

Dehydro Indapamide-d3, CAS: 1185057-48-0, stock: 8.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁D₃ClN₃O₃S.

Des-4-fluorobenzyl Mosapride, CAS: 152013-26-8, stock: 2.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀ClN₃O₃.

Des-4-fluorobenzyl Mosapride-d5, CAS: 1246814-79-8, stock: 4.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅D₅ClN₃O₃.

Des-5’-chloro-4-fluorobenzyl Mosapride, CAS: 170799-30-1, stock: 1.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁N₃O₃.

Descyano Carbamoyl Alogliptin, CAS: /, stock: 3.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃N₅O₃.

Desfluoro Hydroxy Fallypride, CAS: 166173-73-5, stock: 3.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀N₂O₄.

Desmethyl Amisulpride Hydrobromide, CAS: /, stock: 3.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₆BrN₃O₄S.

Desmethyl Amisulpride-d5 Hydrobromide, CAS: /, stock: 3.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁D₅BrN₃O₄S.

Di-o-anisamide, CAS: 858425-08-8, stock: 9.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NO₄.

Dichlorotriphenylphosphorane, CAS: 2526-64-9, stock: 3.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅Cl₂P.

Didox, CAS: 69839-83-4, stock: 7.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₄.

Diethyl 3-Bromo-5-fluorobenzamide, CAS: 1209709-58-9, stock: 9.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃BrFNO.

Diflubenzuron, CAS: 35367-38-5, stock: 3.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉ClF₂N₂O₂.

Dimethyl 3-Bromo-5-fluorobenzamide, CAS: 1235568-08-7, stock: 8.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrFNO.

Disalicylimide, CAS: 1972-71-0, stock: 7.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁NO₄.

Dithio-2,2’-bis(N-methylbenzamide)-d6, CAS: /, stock: 9.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₀D₆N₂O₂S₂.

DS1, CAS: 372497-52-4, stock: 7.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₀Br₂ClN₃OS.

DS2, CAS: 374084-31-8, stock: 9.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂ClN₃OS.

Eact, CAS: 461000-66-8, stock: 3.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄N₂O₅S.

Encainide Hydrochloride, CAS: 66794-74-9, stock: 9.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉ClN₂O₂.

Entinostat(MS-27-275), CAS: 209783-80-2, stock: 2.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀N₄O₃.

Entrectinib, CAS: 1108743-60-7, stock: 9.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₄F₂N₆O₂.

EPPTB, CAS: 1110781-88-8, stock: 5.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁F₃N₂O₂.

EPPTB-d5, CAS: /, stock: 4.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆D₅F₃N₂O₂.

Ethyl 4-bromo-2-fluorobenzamide, CAS: 749927-82-0, stock: 3.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrFNO.

Ethyl 5-Benzyloxy-2-hydroxybenzoate, CAS: 83526-27-6, stock: 9.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₄.

Ethyl 5-bromo-2-chlorobenzamide, CAS: 150079-92-8, stock: 5.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrClNO.

Eticlopride Hydrochloride, CAS: 97612-24-3, stock: 5.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅ClN₂O₃ • ( HCl).

Exalamide, CAS: 53370-90-4, stock: 6.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₂.

exo-IWR-1, CAS: 1127442-87-8, stock: 6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₉N₃O₃.

F-Amidine, CAS: 877617-45-3, stock: 8.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉FN₄O₂.

Fallypride, CAS: 166173-78-0, stock: 7.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₉FN₂O₃.

Farnesyl Thiosalicylic Acid Amide (10 mg/mL in ethanol), CAS: 1092521-74-8, stock: 1.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₁NOS.

Fast Blue BB, CAS: 120-00-3, stock: 5.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₂O₃.

Fast Red Violet LB base, CAS: 121-22-2, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃ClN₂O.

FK 960, CAS: 133920-70-4, stock: 1.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆FN₃O₂.

FLB 457, CAS: 107188-74-9, stock: 4.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃BrN₂O₃.

FLB 457 Hydrobromide, CAS: 107188-92-1, stock: 9.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄Br₂N₂O₃.

Flecainide, CAS: 54143-55-4, stock: 3.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀F₆N₂O₃.

Flecainide Acetate, CAS: 54143-56-5, stock: 1.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄F₆N₂O₅.

Flecainide Meta-O-dealkylated, CAS: 83526-33-4, stock: 5.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉F₃N₂O₃.

Flecainide-d3, CAS: 127413-31-4, stock: 2.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇D₃F₆N₂O₃.

Flecainide-d4, CAS: 1276197-20-6, stock: 7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆D₄F₆N₂O₃.

Fluazuron, CAS: 86811-58-7, stock: 1.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₀Cl₂F₅N₃O₃.

Flucycloxuron, CAS: 113036-88-7, stock: 4.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₀ClF₂N₃O₃.

Flufenoxuron, CAS: 101463-69-8, stock: 8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₁ClF₆N₂O₃.

Fluopyram, CAS: 658066-35-4, stock: 3.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁ClF₆N₂O.

Fluopyram-d4, CAS: /, stock: 8.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₇D₄ClF₆N₂O.

Fluorosalan, CAS: 01/06/4776, stock: 6.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈Br₂F₃NO₂.

Fluralaner, CAS: 864731-61-3, stock: 1.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₇Cl₂F₆N₃O₃.

Fluralaner-13C2,15N,D2, CAS: /, stock: 3.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀¹³C₂H₁₅D₂Cl₂F₆N₂¹⁵NO₃.

Flurofamide, CAS: 70788-28-2, stock: 7.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉FN₃O₂P.

Flurofamide-d4, CAS: /, stock: 3.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅D₄FN₃O₂P.

Flutolanil, CAS: 66332-96-5, stock: 8.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆F₃NO₂.

Flutolanil-d7, CAS: /, stock: 8.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₉D₇F₃NO₂.

Fomesafen, CAS: 72178-02-0, stock: 9.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀ClF₃N₂O₆S.

Foramsulfuron, CAS: 173159-57-4, stock: 5.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₆O₇S.

FPS-ZM1, CAS: 945714-67-0, stock: 7.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂ClNO.

FTBMT, CAS: 1358575-02-6, stock: 7.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆F₄N₄O.

Genfatinib-d3 (Imatinib-d3), CAS: 1134803-18-1, stock: 3.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₈D₃N₇O.

Gleevec (Imatinib Mesylate), CAS: 220127-57-1, stock: 5.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₅N₇O₄S.

Gleevec N-4-((4-Methylpiperazin-1-yl)methyl)benzaldehyde, CAS: 1356565-46-2, stock: 3.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₄₇N₉O₂.

Gleevec-d8 Mesylate (Imatinib-d8 Mesylate), CAS: 1092942-83-0, stock: 4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₇D₈N₇O₄S.

Glyburide, CAS: 10238-21-8, stock: 3.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈ClN₃O₅S.

Glyburide Potassium, CAS: 52169-36-5, stock: 1.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈ClN₃O₅SK.

Glyburide-d11, CAS: 1189985-02-1, stock: 4.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₇D₁₁ClN₃O₅S.

Glycogen Phosphorylase Inhibitor, CAS: 648926-15-2, stock: 8.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅ClF₂N₄O₄.

GNF 7, CAS: 839706-07-9, stock: 5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₄F₃N₇O₂.

GNF-5, CAS: 778277-15-9, stock: 1.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇F₃N₄O₃.

GR 55562 Dihydrochloride, CAS: 159533-25-2, stock: 1.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅N₃O₂ • 2(HCl).

GSK 1838705, CAS: 1116235-97-2, stock: 5.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉FN₈O₃.

GSK 1904529A, CAS: 1089283-49-7, stock: 4.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₄₇F₂N₉O₅S.

GSK 2256098, CAS: 1224887-10-8, stock: 2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃ClN₆O₂.

GSK 269962, CAS: 850664-21-0, stock: 2.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₀N₈O₅.

GSK 923295, CAS: 1088965-37-0, stock: 5.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₈ClN₅O₄.

GSK-1838705A, CAS: 1186659-59-5, stock: 4.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₇FN₈O₃.

GSK2578215A, CAS: 1285515-21-0, stock: 9.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₈FN₃O₂.

GSK5959, CAS: 901245-65-6, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆N₄O₃.

GW 788388, CAS: 452342-67-5, stock: 1.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₃N₅O₂.

GW 788388-d5, CAS: /, stock: 7.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₈D₅N₅O₂.

GZD824, CAS: 1421783-64-3, stock: 4.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₅F₃N₆O₇S₂.

GZD824, CAS: 1257628-77-5, stock: 7.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₇F₃N₆O.

H-Lys(Boc)-OtBu HCl, CAS: 13288-57-8, stock: 4.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₃₁ClN₂O₄.

Halopemide, CAS: 59831-65-1, stock: 3.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂ClFN₄O₂.

Hexaflumuron, CAS: 86479-06-3, stock: 4.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₈Cl₂F₆N₂O₃.

Hexamidine Impurity A Hydrochloride, CAS: /, stock: 7.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆ClN₃O₃.

Hexamidine-d12 Impurity A Hydrochloride, CAS: /, stock: 5.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄D₁₂ClN₃O₃.

HJC0152 Hydrochloride, CAS: 1420290-99-8, stock: 4.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃Cl₂N₃O₄ • HCl.

Hydroxy Glyburide, CAS: 204838-24-4, stock: 9.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈ClN₃O₆S.

Hydroxy Glyburide-d3, CAS: /, stock: 8.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅D₃ClN₃O₆S.

IBZM, CAS: 84226-06-2, stock: 5.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁IN₂O₃.

ICA 069673, CAS: 582323-16-8, stock: 5.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₆ClF₂N₃O.

ICA 110381, CAS: 325457-99-6, stock: 5.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈Cl₂N₂O.

Imatinib (Piperazine)-4-oxide, CAS: 571186-91-9, stock: 2.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₁N₇O₂.

Imatinib (Piperidine)-1-oxide, CAS: 938082-57-6, stock: 5.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₁N₇O₂.

Imatinib (Piperidine)-N,N-dioxide, CAS: 571186-93-1, stock: 9.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₁N₇O₃.

Imatinib (Pyridine)-N-oxide, CAS: 571186-92-0, stock: 2.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₁N₇O₂.

Imatinib Hydrochloride, CAS: 862366-25-4, stock: 7.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₁N₇O  •xHCl.

Imatinib Meta-methyl-piperazine Impurity, CAS: 1246819-59-9, stock: 6.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₁N₇O.

Imatinib Meta-methyl-piperazine Impurity-d3, CAS: 1246819-35-9, stock: 6.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₈D₃N₇O.

Imatinib para-Diaminomethylbenzene, CAS: 1026753-54-7, stock: 3.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₁N₇O.

Imatinib Para-diaminomethylbenzene Impurity Hydrochloride Salt, CAS: /, stock: 7.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₁N₇O xHCl.

Imatinib Para-diaminomethylbenzene Impurity-d3, CAS: 1246819-27-1, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₈D₃N₇O.

Imatinib-d8, CAS: 1092942-82-9, stock: 9.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₃D₈N₇O.

IMD 0354, CAS: 978-62-1, stock: 1.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₈ClF₆NO₂.

IN 1130, CAS: 868612-83-3, stock: 6.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₀N₆O.

INCB 3284 Dimesylate, CAS: 887401-93-6, stock: 7.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₇F₃N₄O₁₀S₂.

Indoramin Hydrochloride, CAS: 38821-52-2, stock: 7.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆ClN₃O.

Indoramin Hydrochloride, CAS: 38821-52-2, stock: 6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅N₃O  • HCl.

Indoramin-d5 Hydrochloride, CAS: 1794970-78-7, stock: 8.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁D₅ClN₃O.

INH6, CAS: 1001753-24-7, stock: 6.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈N₂OS.

Iniparib, CAS: 160003-66-7, stock: 9.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅IN₂O₃.

IRAK-1/4 Inhibitor, CAS: 509093-47-4, stock: 9.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁N₅O₄.

Isoindolin-5-ol Hydrobromide, CAS: 105358-58-5, stock: 7.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO(HBr).

Isopropyl 4-aminobenzamide, CAS: 774-67-4, stock: 4.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O.

Isopropyl 5-bromo-2-chlorobenzamide, CAS: 849898-48-2, stock: 1.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁BrClNO.

Isopropyl-U-47700, CAS: /, stock: 4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆Cl₂N₂O.

Ispinesib, CAS: 336113-53-2, stock: 1.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₃ClN₄O₂.

Itopride, CAS: 122898-67-3, stock: 6.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇ClN₂O₄.

Itopride Hydrochloride, CAS: 122892-31-3, stock: 3.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇ClN₂O₄.

Itopride N-Oxide, CAS: 141996-98-7, stock: 8.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆N₂O₅.

Itopride-d6 Hydrochloride, CAS: 1346601-02-2, stock: 9.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁D₆ClN₂O₄.

IWR-1, CAS: 1127442-82-3, stock: 6.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₉N₃O₃.

ω-Hydroxy-DEET, CAS: 72236-22-7, stock: 6.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₂.

ω-Hydroxy-DEET-D10, CAS: /, stock: 2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇D₁₀NO₂.

α-(Benzoylamino)benzeneacetamide-d10, CAS: 1246814-47-0, stock: 2.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₄D₁₀N₂O₂.

JNJ 63533054, CAS: 1802326-66-4, stock: 5.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇ClN₂O₂.

JTC 801, CAS: 244218-51-7, stock: 9.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₅N₃O₂ • (HCl).

KS 176, CAS: 1253452-78-6, stock: 8.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉N₃O₅.

L 006235, CAS: 294623-49-7, stock: 3.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀N₆O₂S.

Labetalol Hydrochloride, CAS: 32780-64-6, stock: 8.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₅ClN₂O₃.

Labetalol-d3 Hydrochloride (mixture of diastereomers), CAS: /, stock: 1.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂D₃ClN₂O₃.

LDN 193188, CAS: 1267610-30-9, stock: 1.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇Cl₂N₅O₄S.

Levopride, CAS: 23672-07-3, stock: 3.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃N₃O₄S.

Lixivaptan, CAS: 168079-32-1, stock: 10g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₁ClFN₃O₂.

LMK 235, CAS: 1418033-25-6, stock: 8.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂O₄.

Lu AA 47070, CAS: 913842-25-8, stock: 6.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀F₂N₃O₆PS.

Lufenuron, CAS: 103055-07-8, stock: 3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₈Cl₂F₈N₂O₃.

Lufenuron-13C7, CAS: /, stock: 4.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀¹³C₇H₈Cl₂F₈N₂O₃.

LY 2940680, CAS: 1258861-20-9, stock: 3.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₄F₄N₆O.

LY 3000328, CAS: 1373215-15-6, stock: 4.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₉FN₄O₅.

LY 334370 Hydrochloride, CAS: 199673-74-0, stock: 8.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂FN₃O•HCl.

LY-344864 Hydrochloride, CAS: 1217756-94-9, stock: 7.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃ClFN₃O.

m-Carboxycinnamic Acid Bishydroxamide, CAS: 174664-65-4, stock: 9.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₂O₄.

m-Cyanobenzamide, CAS: 08/01/3441, stock: 3.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆N₂O.

m-Nitro-N-octadecylbenzamide, CAS: 109799-65-7, stock: 1.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₂N₂O₃.

m-Toluoyl Chloride, CAS: 1711-06-4, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇ClO.

Masitinib, CAS: 790299-79-5, stock: 8.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₀N₆OS.

MDV 3100 (Enzalutamide), CAS: 915087-33-1, stock: 3.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₆F₄N₄O₂S.

MDV 3100-d3, CAS: 1443331-82-5, stock: 7.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₃D₃F₄N₄O₂S.

MDV 3100-d6 (Enzalutamide-d6), CAS: 1443331-94-9, stock: 6.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₀D₆F₄N₄O₂S.

Medroxalol, CAS: 56290-94-9, stock: 4.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₅.

Mepronil, CAS: 55814-41-0, stock: 1.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NO₂.

Methyl 3-Amino-4-methylbenzoate, CAS: 18595-18-1, stock: 4.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₂.

Methyl 3-Iodo-4-methylbenzoate, CAS: 90347-66-3, stock: 3.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉IO₂.

Methyl 4-bromo-2-methoxybenzamide, CAS: 1228957-03-6, stock: 8.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀BrNO₂.

Methyl 4-Methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzoate, CAS: 917392-54-2, stock: 7.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆N₄O₂.

Methyl 5-bromo-2-chlorobenzamide, CAS: 435273-54-4, stock: 9.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇BrClNO.

Methyl Succinamate, CAS: 53171-39-4, stock: 9.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO₃.

Metoclopramide, CAS: 364-62-5, stock: 2.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂ClN₃O₂.

Metoclopramide Hydrochloride, CAS: 7232-21-5, stock: 9.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃Cl₂N₃O₂.

Metoclopramide N-Oxide, CAS: 171367-22-9, stock: 1.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂ClN₃O₃.

Metoclopramide-d3, CAS: 1216522-89-2, stock: 6.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉D₃ClN₃O₂.

Metoclopramide-d3 N-Oxide, CAS: 1246816-54-5, stock: 10g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉D₃ClN₃O₃.

MI-192, CAS: 1415340-63-4, stock: 4.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁N₃O₂.

Midostaurin, CAS: 120685-11-2, stock: 6.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₀N₄O₄.

Mivazerol, CAS: 125472-02-8, stock: 8.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁N₃O₂.

ML 161, CAS: 423735-93-7, stock: 3.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇BrN₂O₂.

ML 339, CAS: 2080300-49-6, stock: 8.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₂ClN₃O₅.

ML 352, CAS: 1649450-12-3, stock: 6.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₉N₃O₄.

ML 365, CAS: 947914-18-3, stock: 5.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀N₂O₃.

ML 382, CAS: 1646499-97-9, stock: 4.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀N₂O₄S.

ML 786 Dihydrochloride, CAS: 1237536-18-3, stock: 1.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₉F₃N₄O₃ • 2(HCl).

ML-299, CAS: 1426916-00-8, stock: 6.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆BrFN₄O₂.

ML298, CAS: 95%, stock: 2.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃F₃N₄O₂.

ML324, CAS: 1222800-79-4, stock: 5.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃N₃O₂.

ML335, CAS: 825658-06-8, stock: 7.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄Cl₂N₂O₃S.

ML364, CAS: 1991986-30-1, stock: 2.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₈F₃N₃O₃S₂.

MMP Inhibitor V, CAS: 223472-31-9, stock: 8.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈N₂O₆.

Mocetinostat, CAS: 726169-73-9, stock: 7.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₀N₆O.

Moclobemide, CAS: 71320-77-9, stock: 5.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇ClN₂O₂.

Moclobemide N-Oxide, CAS: 64544-24-7, stock: 4.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇ClN₂O₃.

Moclobemide-d8, CAS: /, stock: 1.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉D₈ClN₂O₂.

Modecainide, CAS: 81329-71-7, stock: 1.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈N₂O₃.

Monepantel, CAS: /, stock: 5.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₃F₆N₃O₂S.

Monepantel Sulfone, CAS: /, stock: 5.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₃F₆N₃O₄S.

mono-Methyl Terephthalate, CAS: 1679-64-7, stock: 1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₄.

Mosapride, CAS: 112885-41-3, stock: 3.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅ClFN₃O₃.

Mosapride Citrate Dihydrate, CAS: 636582-62-2, stock: 4.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇ClFN₃O₁₂.

Mosapride N-Oxide, CAS: 1161443-73-7, stock: 6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅ClFN₃O₄.

Mosapride-d5, CAS: 1246820-66-5, stock: 4.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀D₅ClFN₃O₃.

Mosapride-d5 N-Oxide, CAS: 1246816-63-6, stock: 5.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀D₅ClFN₃O₄.

Mozavaptan, CAS: 137975-06-5, stock: 1.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉N₃O₂.

Mps BAY 2a, CAS: 1382477-96-4, stock: 7.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₈N₆O.

MRT 10, CAS: 330829-30-6, stock: 8.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃N₃O₅S.

Myxochelin A, CAS: 120243-02-9, stock: 4.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₇.

N, N-Diisopropyl 2-bromo-5-fluorobenzamide, CAS: 951884-15-4, stock: 7.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇BrFNO.

N,2-Dimethyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, CAS: 1233526-90-3, stock: 4.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂BNO₃.

N,3-Dihydroxy-4-methylbenzamide, CAS: 1016847-61-2, stock: 7.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₃.

N,4-Dimethoxy-N-methylbenzamide, CAS: 52898-49-4, stock: 5.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₃.

N,​N-Diethyl-​4-​(5-​hydroxyspiro[2H-​1-​benzopyran-​2,​4’-​piperidin]​-​4-​yl)​-​benzamide Hydrochloride, CAS: 850173-95-4, stock: 7.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉ClN₂O₃.

N,N,2-Trimethyl-5-nitro-benzamide,, CAS: 130370-02-4, stock: 8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₃.

N,N-Bis(1-methylethyl)-2-(1-naphthalenyl)-benzamide, CAS: 132464-44-9, stock: 8.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅NO.

N,N-Diacetyl Des-4-fluorobenzyl Mosapride, CAS: 170799-32-3, stock: 3.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄ClN₃O₅.

N,N-Diacetyl Des-5’-chloro-4-fluorobenzyl Mosapride, CAS: 170799-31-2, stock: 5.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅N₃O₅.

N,N-Dibutyl 2-bromobenzamide, CAS: 349092-70-2, stock: 8.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂BrNO.

N,N-Diethyl 2-fluorobenzamide, CAS: 10345-76-3, stock: 4.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄FNO.

N,N-Diethyl 3-borono-4-fluorobenzamide, CAS: 874289-47-1, stock: 3.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅BFNO₃.

N,N-Diethyl 3-bromo-5-nitrobenzamide, CAS: 929000-34-0, stock: 1.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃BrN₂O₃.

N,N-Diethyl 4-(Aminomethyl)benzamide, CAS: 926189-99-3, stock: 1.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O.

N,N-Diethyl 4-bromo-2-chlorobenzamide, CAS: 682778-17-2, stock: 6.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃BrClNO.

N,N-Diethyl 4-bromo-3-methoxybenzamide, CAS: 889676-36-2, stock: 1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆BrNO₂.

N,N-Diethyl-2-bromobenzamide, CAS: 76041-86-6, stock: 9.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄BrNO.

N,N-Diethyl-2-iodobenzamide, CAS: 76041-87-7, stock: 1.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄INO.

N,N-Diethyl-2-methylbenzamide, CAS: 03/04/2728, stock: 5.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO.

N,N-Diethyl-2-[(2-methylphenyl)(phenylmethyl)amino]-benzamide-d7, CAS: /, stock: 2.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₁D₇N₂O.

N,N-Diethyl-2-[(2-methylphenyl)amino]-benzamide-d7, CAS: /, stock: 3.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅D₇N₂O.

N,N-Diethyl-3-iodobenzamide, CAS: 15930-60-6, stock: 6.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄INO.

N,N-Diethyl-4-(2-hydroxyphenyl)benzamide, CAS: 356072-33-8, stock: 8.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NO₂.

N,N-Diethyl-4-(phenyl-4-piperidinylidenemethyl)benzamide Hydrochloride, CAS: 209808-47-9, stock: 5.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉ClN₂O.

N,N-Diethyl-4-bromobenzamide, CAS: 5892-99-9, stock: 6.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄BrNO.

N,N-Diethyl-4-Fluorobenzamide, CAS: 10366-88-8, stock: 4.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄NOF.

N,N-Diethyl-4-iodobenzamide, CAS: 77350-52-8, stock: 5.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄INO.

N,N-Diethyl-4-nitrobenzamide, CAS: 5323-47-7, stock: 2.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O₃.

N,N-Diethyl-p-toluamide, CAS: 04/05/2728, stock: 5.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO.

N,N-Diethylbenzamide, CAS: 1696-17-9, stock: 3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO.

N,N-Diethylbenzamide-d5, CAS: /, stock: 2.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀D₅NO.

N,N-Diisopropyl 2-Bromobenzamide, CAS: 6641-72-1, stock: 10g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈BrNO.

N,N-Diisopropyl 4-bromo-3-methoxybenzamide, CAS: 1072944-37-6, stock: 1.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀BrNO₂.

N,N-Diisopropyl-3-nitrobenzamide, CAS: 08/06/2448, stock: 7.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₃.

N,N-Diisopropyl-4-bromo-3-methylbenzamide, CAS: 52010-31-8, stock: 3.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀BrNO.

N,N-Dimethyl 2-bromo-5-fluorobenzamide, CAS: 951884-08-5, stock: 6.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrFNO.

N,N-Dimethyl 2-bromobenzamide, CAS: 54616-47-6, stock: 3.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀BrNO.

N,N-Dimethyl 3-borono-4-fluorobenzamide, CAS: 874289-46-0, stock: 3.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁BFNO₃.

N,N-Dimethyl 3-bromo-5-nitrobenzamide, CAS: 929000-26-0, stock: 2.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrN₂O₃.

N,N-Dimethyl 3-bromobenzamide, CAS: 24167-51-9, stock: 5.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀BrNO.

N,N-Dimethyl 4-Aminobenzamide, CAS: 6331-71-1, stock: 6.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O.

N,N-Dimethyl 4-bromo-2-chlorobenzamide, CAS: 893420-19-4, stock: 2.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrClNO.

N,N-Dimethyl 4-bromo-3-methoxybenzamide, CAS: 1065074-12-5, stock: 4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂BrNO₂.

N,N-Dimethyl 4-bromobenzamide, CAS: 18469-37-9, stock: 6.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀BrNO.

N,N-Dimethyl 4-chlorobenzamide, CAS: 14062-80-7, stock: 5.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀ClNO.

N,N-Dimethyl 5-bromo-2-chlorobenzamide, CAS: 701258-20-0, stock: 9.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrClNO.

N,N-Dimethyl-3-(4-nitrophenyl)benzamide, CAS: 1365272-33-8, stock: 2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₂O₃.

N,N-Dimethyl-3-nitrobenzamide, CAS: 03/02/7291, stock: 2.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O₃.

N,N-Dimethyl-4-(3-nitrophenyl)benzamide, CAS: 1355247-88-9, stock: 1.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₂O₃.

N,N-Dimethyl-4-(4-nitrophenyl)benzamide, CAS: 1355247-57-2, stock: 3.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₂O₃.

N,N-dimethyl-4-(trifluoromethyl)benzamide, CAS: 25771-21-5, stock: 4.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀F₃NO.

N,N-Dimethyl-4-nitrobenzamide, CAS: 02/01/7291, stock: 4.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O₃.

N,N-Diphenyl-4-methoxybenzamide, CAS: 16034-40-5, stock: 7.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇NO₂.

N,N’-((Ethane-1,2-diylbis(azanediyl))bis(ethane-2,1-diyl))dibenzamide, CAS: 878580-53-1, stock: 3.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆N₄O₂.

N,N’-((sulfonylbis(4,1-phenylene))bis(ethane-2,1-diyl))bis(5-chloro-2-methoxybenzamide), CAS: 1797029-88-9, stock: 6.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₀Cl₂N₂O₆S.

N,N’-(5,5’-(Methylenebis(azanediyl))bis(6-(2,3-dichlorophenyl)-1,2,4-triazine-5,3-diyl))bis(2,3-dichlorobenzamide), CAS: /, stock: 8.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₁₈Cl₈N₁₀O₂.

N,N’-(Ehane-1,2-diyl)bis(N-(2-aminoethyl)benzamide), CAS: /, stock: 6.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆N₄O₂.

N,N’-(Ethane-1,2-diyl)bis(N-(2-benzamidoethyl)benzamide), CAS: 107676-42-6, stock: 2.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₄N₄O₄.

N,N’-1,4-Phenylenebis[2,5-dichlorobenzamide], CAS: 548779-60-8, stock: 7.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂Cl₄N₂O₂.

N,N’-[(1S,2S)-1,2-Diphenyl-1,2-ethanediyl]bis[2-(diphenylphosphino)benzamide, CAS: 143668-57-9, stock: 9.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₄₂N₂O₂P₂.

N,N’-[6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diyl]bis[2,3-dichlorobenzamide, CAS: 1373393-59-9, stock: 3.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₁Cl₆N₅O₂.

N-((1-(2-(tert-Butylamino)-2-oxoethyl)piperidin-4-yl)methyl)-3-chloro-5-fluorobenzamide, CAS: 1199236-64-0, stock: 3.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₇ClFN₃O₂.

N-((1-(2-(tert-Butylamino)-2-oxoethyl)piperidin-4-yl)methyl)-3-chloro-5-fluorobenzamide-d9 Hydrochloride Salt, CAS: 1346604-21-4, stock: 4.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉D₉Cl₂FN₃O₂.

N-((2-Bromo-6-fluorophenyl)carbamothioyl)benzamide, CAS: /, stock: 5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀BrFN₂OS.

N-((3S,4R)-3-(3,4-Dimethoxyphenyl)-1-methylpiperidin-4-yl)-4-nitrobenzamide, CAS: /, stock: 6.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅N₃O₅.

N-(1-Benzyl-4-piperidinyl)benzamide(Indoramin Impurity), CAS: 971-34-6, stock: 4.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂N₂O.

N-(1-benzyl-6-methyl-1,2,5,6-tetrahydropyridin-3-yl)benzamide, CAS: 1443979-52-9, stock: 1.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂N₂O.

N-(1-carbamothioyl-1-methylpropyl)benzamide, CAS: 1292939-21-9, stock: 5.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂OS.

N-(1-carbamothioylbutyl)benzamide, CAS: 1283049-26-2, stock: 5.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂OS.

N-(1-carbamothioylcyclohexyl)benzamide, CAS: 1284015-89-9, stock: 4.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₂OS.

N-(1-carbamothioylcyclopentyl)benzamide, CAS: 1274493-24-1, stock: 5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂OS.

N-(1-Chloro-2-oxo-2-phenylethyl)benzamide, CAS: 41260-69-9, stock: 4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂ClNO₂.

N-(1-Cyano-2-hydroxy-1-methylethyl)-4-[(trifluoromethyl)thio]-benzamide, CAS: 1036762-89-6, stock: 4.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁F₃N₂O₂S.

N-(1-Cyanobutyl)benzamide, CAS: 107694-53-1, stock: 6.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O.

N-(1-cyanocyclobutyl)benzamide, CAS: 1306604-17-0, stock: 4.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂N₂O.

N-(1H-Indol-5-yl)benzamide, CAS: 6019-39-2, stock: 8.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂N₂O.

N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-4-(4-methyl-1,1-dioxido-3-oxo-2-isothiazolidinyl)benzamide, CAS: 1011702-84-3, stock: 6.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈N₂O₆S.

N-(2,3-Dimethylphenyl) 4-boronobenzamide, CAS: 913835-36-6, stock: 1.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆BNO₃.

N-(2,3-Dimethylphenyl) Mefenamic Acid Carboxamide, CAS: 21122-68-9, stock: 9.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄N₂O.

N-(2,4-Difluorophenyl) 2-bromobenzamide, CAS: 314025-94-0, stock: 7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈BrF₂NO.

N-(2,4-Dimethylphenyl) 4-boronobenzamide, CAS: 913835-38-8, stock: 6.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆BNO₃.

N-(2,5-Dimethylphenyl) 4-boronobenzamide, CAS: 913835-40-2, stock: 1.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆BNO₃.

N-(2,6-Dimethylphenyl) 2-bromobenzamide, CAS: 195383-89-2, stock: 3.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄BrNO.

N-(2-((2-((2-Aminoethyl)amino)ethyl)amino)ethyl]benzamide, CAS: 229499-92-7, stock: 5.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₂N₄O.

N-(2-((2-Aminoethyl)amino)ethyl)-N-(2-benzamidoethyl)benzamide, CAS: /, stock: 1.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆N₄O₂.

N-(2-(1,3-Dioxoisoindolin-2-yl)ethoxy)benzamide, CAS: 123529-05-5, stock: 1.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄N₂O₄.

N-(2-(1,3-Dioxoisoindolin-2-yl)ethoxy-d4)benzamide, CAS: /, stock: 1.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₀D₄N₂O₄.

N-(2-(Cyclopropanecarboxamido)ethyl)-2-fluoro-N-(2-hydroxyethyl)-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzamide, CAS: /, stock: 3.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅FN₄O₄.

N-(2-Amino-4-methoxyphenyl)-4-hydroxybenzamide, CAS: 1016704-90-7, stock: 2.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄N₂O₃.

N-(2-Amino-5-chlorophenyl)-4-hydroxybenzamide, CAS: 1016495-74-1, stock: 2.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁N₂O₂Cl.

N-(2-Aminoethyl)-2,4-difluorobenzamide Hydrochloride, CAS: 1235439-38-9, stock: 4.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂OF₂ • HCl.

N-(2-aminoethyl)-2,6-difluorobenzamide hydrochloride, CAS: 1311317-04-0, stock: 6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂OF₂.HCl.

N-(2-Aminoethyl)-2-(trifluoromethyl)benzamide Hydrochloride, CAS: 1171228-13-9, stock: 9.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁N₂OF₃ • HCl.

N-(2-Aminoethyl)-4-chlorobenzamide Hydrochloride, CAS: 94319-79-6, stock: 8.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂Cl₂N₂O.

N-(2-aminoethyl)-4-iodobenzamide hydrochloride, CAS: 145343-82-4, stock: 1.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₂OI.HCl.

N-(2-Aminoethyl)-N-(2-((2-benzamidoethyl)amino)ethyl)benzamide, CAS: /, stock: 1.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆N₄O₂.

N-(2-Aminoethyl)benzamide, CAS: 1009-17-2, stock: 8.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O.

N-(2-Aminophenyl)-4-[[[(4S)-4,5-dihydro-4-phenyl-2-thiazolyl]amino]methyl]-benzamide, CAS: 1448350-50-2, stock: 3.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂N₄OS.

N-(2-Benzamidoethyl)-N-(2-((2-benzamidoethyl)amino)ethyl)benzamide, CAS: /, stock: 4.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀N₄O₃.

N-(2-Bromoethyl)-2-methoxy-benzamide, CAS: 1152510-06-9, stock: 9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂NO₂Br.

N-(2-carbamothioyl-2-methylethyl)-N-methylbenzamide, CAS: 1247440-04-5, stock: 4.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂OS.

N-(2-carbamothioyl-2-methylethyl)benzamide, CAS: 1248302-41-1, stock: 7.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂OS.

N-(2-Chloro-4-methylphenyl) 4-boronobenzamide, CAS: 913835-39-9, stock: 9.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃BClNO₃.

N-(2-Chloro-5-methyl-4-nitrophenyl)benzamide, CAS: 206986-83-6, stock: 8.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁ClN₂O₃.

N-(2-Chloroethyl) 3-boronobenzamide, CAS: 874288-12-7, stock: 4.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁BClNO₃.

N-(2-Chloroethyl) 4-boronobenzamide, CAS: 874460-05-6, stock: 6.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁BClNO₃.

N-(2-Chloroethyl)benzamide, CAS: 26385-07-9, stock: 7.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀ClNO.

N-(2-Chloropyridin-3-yl)-2-nitrobenzamide, CAS: 1028-86-0, stock: 9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈ClN₃O₃.

N-(2-Cyanoethyl)-4-(1,3,2-dioxaborinan-2-yl)benzamide, CAS: 1073372-08-3, stock: 9.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅BN₂O₃.

N-(2-Cyanophenyl)-3,4-difluorobenzamide, CAS: 1016804-69-5, stock: 2.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈N₂OF₂.

N-(2-cyclopropyl-2-hydroxyethyl)-2-(trifluoromethyl)benzamide, CAS: 1273988-45-6, stock: 1.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄NO₂F₃.

N-(2-Fluorophenyl) 3-boronobenzamide, CAS: 874288-35-4, stock: 5.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁BFNO₃.

N-(2-Hydroxy-1,1-dimethylethyl)benzamide-d5, CAS: /, stock: 7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀D₅NO₂.

N-(2-Hydroxyethyl) 2-bromo-5-fluorobenzamide, CAS: 951884-16-5, stock: 9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrFNO₂.

N-(2-Hydroxyethyl) 4-borono-2-fluorobenzamide, CAS: 874289-21-1, stock: 6.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁BFNO₄.

N-(2-Hydroxyethyl)-3-nitrobenzamide, CAS: 7399-69-1, stock: 6.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O₄.

N-(2-Oxo-2-phenylethyl)-N-phenylbenzamide, CAS: 54901-99-4, stock: 3.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₇NO₂.

N-(2-Pyridinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide(Flecainide Impurity), CAS: 57415-36-8, stock: 1.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄F₆N₂O₃.

N-(3,4-Difluorophenyl) 3-boronobenzamide, CAS: 1072946-15-6, stock: 3.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀BF₂NO₃.

N-(3,4-Difluorophenyl)-2-fluoro-5-[[[(1R)-1-methylpropyl]amino]sulfonyl]benzamide, CAS: 1572510-80-5, stock: 5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇F₃N₂O₃S.

N-(3,4-Dimethoxybenzyl)-2-fluoro-5-nitrobenzamide, CAS: 247568-67-8, stock: 8.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅FN₂O₅.

N-(3,4-Dimethylphenyl) 2-bromobenzamide, CAS: 303991-53-9, stock: 4.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄BrNO.

N-(3,5-Dichloro-4-pyridinyl)-3,4-dihydroxybenzamide, CAS: 1412448-29-3, stock: 4.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈Cl₂N₂O₃.

N-(3-Acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide, CAS: 136450-06-1, stock: 8.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₅NO₄.

N-(3-Aminopropyl)-3-bromobenzamide, CAS: 1016507-95-1, stock: 7.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₂OBr.

N-(3-aminopropyl)-3-fluorobenzamide hydrochloride, CAS: 1280980-98-4, stock: 4.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₂OF.HCl.

N-(3-Aminopropyl)-3-hydroxybenzamide, CAS: 1016770-44-7, stock: 3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₂.

N-(3-Aminopropyl)-4-bromobenzamide, CAS: 1016790-51-4, stock: 9.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₂OBr.

N-(3-aminopropyl)-4-fluorobenzamide hydrochloride, CAS: 1281179-38-1, stock: 4.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₂OF.HCl.

N-(3-Aminopropyl)-4-hydroxybenzamide Hydrochloride, CAS: 1240527-77-8, stock: 3.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₂ • HCl.

N-(3-aminopyridin-4-yl)-4-ethoxybenzamide, CAS: 1281215-72-2, stock: 1.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N₃O₂.

N-(3-Azetidinyl)-3-methoxybenzamide Hydrochloride, CAS: 1401425-77-1, stock: 9.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O₂.HCl.

N-(3-Bromophenyl)benzamide, CAS: 10286-85-8, stock: 1.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀NOBr.

N-(3-Bromopropyl) 3-boronobenzamide, CAS: 850567-42-9, stock: 4.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃BBrNO₃.

N-(3-Bromopropyl) 4-Boronobenzamide, CAS: 850567-41-8, stock: 1.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃BBrNO₃.

N-(3-chloro-2-fluorophenyl)-3-cyano-5-fluorobenzamide, CAS: 1243310-20-4, stock: 3.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₇ClF₂N₂O.

N-(3-Chloro-2-methylphenyl) 3-Boronobenzamide, CAS: 1072946-02-1, stock: 2.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃BClNO₃.

N-(3-Chloro-4-fluorophenyl) 3-Boronobenzamide, CAS: 1072946-04-3, stock: 4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀BClFNO₃.

N-(3-Chloro-4-methylphenyl) 4-boronobenzamide, CAS: 913835-37-7, stock: 7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃BClNO₃.

N-(3-Chloropropyl) 3-boronobenzamide, CAS: 874288-10-5, stock: 1.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃BClNO₃.

N-(3-Cyanophenyl)benzamide, CAS: 141990-91-2, stock: 9.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀N₂O.

N-(3-Guanidino-4-methylphenyl)-4-(methylpiperazine-1-yl-methyl)benzamide Dihydrochloride, CAS: 581076-67-7, stock: 8.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀Cl₂N₆O.

N-(3-Methoxypropyl)-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, CAS: 1509932-25-5, stock: 8.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₆BNO₄.

N-(3-methyl-2-oxobutyl)-4-nitrobenzamide, CAS: 1311317-41-5, stock: 4.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₄.

N-(3-Nitrophenyl)benzamide, CAS: 08/08/4771, stock: 8.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀N₂O₃.

N-(3-Trimethoxysilylpropyl)-4-azido-2,3,5,6-tetrafluorobenzamide >90%, CAS: 298225-03-3, stock: 7.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆F₄N₄O₄Si.

N-(4,4’-Dinitro-biphenyl-2-yl)benzamide, CAS: 84682-33-7, stock: 6.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₃N₃O₅.

N-(4-(2-Amino-1-(4-chlorophenyl)-2-oxoethyl)-5-chloro-2-methylphenyl)-2-hydroxy-3,5-diiodobenzamide, CAS: /, stock: 7.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₆Cl₂I₂N₂O₃.

N-(4-Amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide, CAS: 10558-45-9, stock: 7.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀N₂O₂Cl₂.

N-(4-Amino-2-methylphenyl)benzamide, CAS: 104478-99-1, stock: 2.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄N₂O.

N-(4-amino-3-methylphenyl)-3-chlorobenzamide, CAS: 1285097-46-2, stock: 8.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃N₂OCl.

N-(4-Amino-5-methoxy-2-methylphenyl)benzamide, CAS: 99-21-8, stock: 9.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆N₂O₂.

N-(4-Aminophenyl)-3-chlorobenzamide, CAS: 123098-38-4, stock: 6.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁N₂OCl.

N-(4-Aminophenyl)-4-tert-butylbenzamide, CAS: 129488-55-7, stock: 3.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₂O.

N-(4-Bromo-2-chlorophenyl)-5-chloro-2-hydroxybenzamide, CAS: 1098360-68-9, stock: 8.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈NO₂Cl₂Br.

N-(4-Bromophenyl)-2-chloro-benzamide, CAS: 66569-05-9, stock: 3.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉BrClNO.

N-(4-Chloro-2-methylphenyl)-4-(N’-hydroxycarbamimidoyl)benzamide, CAS: 1097079-26-9, stock: 9.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₃O₂Cl.

N-(4-Chloro-phenyl)-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzamide, CAS: 2096339-42-1, stock: 6.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁BClNO₃.

N-(4-Chlorophenyl) 2-bromobenzamide, CAS: 66569-06-0, stock: 2.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉BrClNO.

N-(4-Chlorophenyl)-2,6-difluorobenzamide, CAS: 122987-01-3, stock: 9.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈NOF₂Cl.

N-(4-Cyanophenyl)-3,4-difluorobenzamide, CAS: 1007802-68-7, stock: 7.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈N₂OF₂.

N-(4-Fluorobenzoyl)-5-amino-1H-indole, CAS: 182564-41-6, stock: 7.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁FN₂O.

N-(4-Hydroxybenzyl)-3,4-dimethoxybenzamide, CAS: 943518-63-6, stock: 6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇NO₄.

N-(4-Hydroxyphenyl)-N,4-dimethylbenzamide, CAS: 1148-53-4, stock: 1.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO₂.

N-(4-Methoxybenzyl) 4-boronobenzamide, CAS: 874460-08-9, stock: 8.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆BNO₄.

N-(4-Methyl-3-aminophenyl)-4-(4-methylpiperazinomethyl)benzamide, CAS: 581076-63-3, stock: 4.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆N₄O.

N-(4-Methyl-3-nitrophenyl)-4-(4-methylpiperazinomethyl)benzamide, CAS: 581076-60-0, stock: 7.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₄O₃.

N-(4-Methyl-3-nitrophenyl)-4-chloromethylbenzamide, CAS: 851319-32-9, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃ClN₂O₃.

N-(4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)benzamide, CAS: 13097-06-8, stock: 1.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈N₂O₂S₂.

N-(4-Pyrrolidinobenzyl) 4-pyrrolidinobenzamide, CAS: 1423037-21-1, stock: 4.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇N₃O.

N-(4’’-(dimethylamino)-5’-(4-(dimethylamino)phenyl)-4’-hydroxy-[1,1’:3’,1’’-terphenyl]-4-yl)-N-methyl-4-(methylamino)benzamide, CAS: /, stock: 6.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₈N₄O₂.

N-(5-(4-((2-Hydroxyphenyl)amino)-3,6-dioxocyclohexa-1,4-dien-1-yl)-1,3,4-thiadiazol-2-yl)benzamide, CAS: /, stock: 5.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₄N₄O₄S.

N-(5-(4-((3,4,5,6-D4-2-Hydroxyphenyl)amino)-3,6-dioxocyclohexa-1,4-dien-1-yl)-1,3,4-thiadiazol-2-yl)benzamide, CAS: /, stock: 4.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₀D₄N₄O₄S.

N-(5-Amino-2-methoxyphenyl)-4-chloro-2-fluorobenzamide, CAS: 1016696-80-2, stock: 5.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂N₂O₂FCl.

N-(5-Amino-2-methoxyphenyl)benzamide, CAS: 119-88-0, stock: 3.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄N₂O₂.

N-(5-Chloro-2-methoxy-13CD3-benzoyl)-4-[2-(5-Chloro-2-methoxy-13CD3-benzamido)ethyl]benzene Sulfonamide, CAS: /, stock: 4.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂¹³C₂H₁₆D₆Cl₂N₂O₆S.

N-(5-Chloro-2-methoxybenzoyl)-4-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzene Sulfonamide, CAS: /, stock: 4.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂Cl₂N₂O₆S.

N-(5-Chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)-2-hydroxy-5-iodobenzamide, CAS: /, stock: 8.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₅Cl₂IN₂O₂.

N-(5-Guanidino-1-((4-nitrophenyl)amino)-1-oxopentan-2-yl)benzamide Hydrochloride, CAS: 911-77-3, stock: 1.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂N₆O₄ • HCl.

N-(5-iodo-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, CAS: 145913-85-5, stock: 5.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈N₃O₂I.

N-(5-methyl-2-oxo-2,3-dihydropyrimidin-4-yl)benzamide, CAS: 126354-30-1, stock: 7.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁N₃O₂.

N-(6-Aminohexanoyl) Pomalidomide BP-1-108 Amide, CAS: /, stock: 7.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₁H₅₈N₆O₁₀S.

N-(6-aminopyridin-3-yl)-4-methoxybenzamide, CAS: 1290702-34-9, stock: 5.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₃O₂.

N-(6-Bromopyridin-2-yl)benzamide, CAS: 1153903-18-4, stock: 4.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉N₂OBr.

N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, CAS: 110764-72-2, stock: 7.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₃₇N₅O₇.

N-(carbamimidoylmethyl)-N-cyclopropylbenzamide hydrochloride, CAS: 1334146-26-7, stock: 7.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅N₃O.HCl.

N-(cyanomethyl)-N-cyclopropylbenzamide, CAS: 1252203-40-9, stock: 2.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂N₂O.

N-(Furan-2-ylmethyl) 2-bromo-5-fluorobenzamide, CAS: 923722-86-5, stock: 8.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉BrFNO₂.

N-(Furan-2-ylmethyl) 3-bromo-4-fluoro-benzamide, CAS: 1065074-07-8, stock: 6.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉BrFNO₂.

N-(Furan-2-ylmethyl) 4-bromo-3-methoxybenzamide, CAS: 1072944-36-5, stock: 5.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂BrNO₃.

N-(Furan-2-ylmethyl) 4-bromo-3-methylbenzamide, CAS: 1072944-32-1, stock: 8.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂BrNO₂.

N-(Furan-2-ylmethyl) 4-bromobenzamide, CAS: 312587-75-0, stock: 2.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀BrNO₂.

N-(p-Chlorobenzoyl)-p-anisidine, CAS: 4018-82-0, stock: 8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂ClNO₂.

N-(piperidin-2-ylmethyl)benzamide, CAS: 127722-73-0, stock: 6.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O.

N-(Piperidin-4-yl)methyl-3-chloro-5-fluorobenzamide, CAS: 1391051-83-4, stock: 2.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆ClFN₂O.

N-(Prop-2-yn-1-yl)-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, CAS: 1357387-28-0, stock: 6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀BNO₃.

N-(tert-Butyloxycarbonyl-piperidin-4-yl)methyl-3-chloro-5-fluorobenzamide, CAS: 1797134-47-4, stock: 3.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄ClFN₂O₃.

N-(Tetrahydro-2H-pyran-4-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, CAS: 656239-37-1, stock: 3.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆BNO₄.

N-1H-Imidazol-2-yl-formamide, CAS: 229343-10-6, stock: 6.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅N₃O.

N-2-Fluorophenyl 4-boronobenzamide, CAS: 874288-06-9, stock: 4.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁BFNO₃.

N-3-Fluorophenyl 4-boronobenzamide, CAS: 874288-05-8, stock: 4.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁BFNO₃.

N-4-Bromophenyl 4-boronobenzamide, CAS: 874287-99-7, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁BBrNO₃.

N-4-Fluorophenyl-3-(trifluoromethyl)benzamide, CAS: 33489-71-3, stock: 9.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉F₄NO.

N-Acetal Bromopride, CAS: 94135-22-5, stock: 3.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄BrN₃O₃.

N-Acetyl Metoclopramide, CAS: 5608-13-9, stock: 7.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄ClN₃O₃.

N-Acetyl Metoclopramide-d3, CAS: 105314-01-0, stock: 7.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁D₃ClN₃O₃.

N-Acetylprocainamide Hydrochloride, CAS: 34118-92-8, stock: 6.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄ClN₃O₂.

N-Allyl-2-hydroxybenzamide, CAS: 118-62-7, stock: 2.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₂.

N-​Methyl-​2-​[[3-​[(1E)​-​2-​(1-​oxido-​2-​pyridinyl)​ethenyl]​-​1H-​indazol-​6-​yl]​sulfinyl]​-benzamide, CAS: 1348044-24-5, stock: 8.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈N₄O₃S.

N-​[[1-​(Dimethylamino)​cyclohexyl]​methyl]​-benzamide, CAS: 63886-94-2, stock: 6.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄N₂O.

N-​[[3-​(4-​fluorophenyl)​-​2-​oxo-​5-​oxazolidinyl]​methyl]​-​4-​(trifluoromethyl)​-Benzamide, CAS: 954642-81-0, stock: 1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄F₄N₂O₃.

N-Benzoyl-5’-O-[bis(4-methoxyphenyl)phenylmethyl]-2’-O-(2-methoxyethyl)-adenosine, CAS: 251647-48-0, stock: 1.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₁N₅O₈.

N-Benzoyl-N-(2-phenylethyl)benzamide, CAS: 74449-34-6, stock: 7.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉NO₂.

N-Benzoyldeoxycytidine, CAS: 4836-13-9, stock: 2.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₃O₅.

N-Benzyl 2-bromo-5-fluorobenzamide, CAS: 951884-18-7, stock: 8.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁BrFNO.

N-Benzyl 2-bromobenzamide, CAS: 82082-50-6, stock: 8.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂BrNO.

N-Benzyl 3-borono-4-fluorobenzamide, CAS: 874289-53-9, stock: 3.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃BFNO₃.

N-Benzyl 3-bromobenzamide, CAS: 161258-41-9, stock: 1.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂BrNO.

N-Benzyl 4-Borono-2-fluorobenzamide, CAS: 874289-19-7, stock: 7.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃BFNO₃.

N-Benzyl 4-bromo-3-methylbenzamide, CAS: 1020252-76-9, stock: 2.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄BrNO.

N-Benzyl 4-bromobenzamide, CAS: 80311-89-3, stock: 8.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂BrNO.

N-Benzyl-2-iodobenzamide, CAS: 73178-23-1, stock: 9.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂INO.

N-Benzyl-3-(2-sulfanyl-1H-imidazol-1-yl)benzamide, CAS: 1146290-00-7, stock: 9.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅N₃OS.

N-Benzyl-3-fluorobenzamide, CAS: 671-01-2, stock: 3.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂FNO.

N-Benzyl-3-iodobenzamide, CAS: 82082-51-7, stock: 6.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂INO.

N-Benzyl-4-(2-sulfanyl-1H-imidazol-1-yl)benzamide, CAS: 1146289-95-3, stock: 8.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅N₃OS.

N-Benzyl-N-ethyl 4-boronobenzamide, CAS: 913835-41-3, stock: 8.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈BNO₃.

N-Benzyl-N-methyl 2-bromobenzamide, CAS: 124461-28-5, stock: 2.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄BrNO.

N-Benzylbenzamide, CAS: 1485-70-7, stock: 5.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃NO.

N-Benzyloxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzamide, CAS: 2096330-26-4, stock: 9.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄BNO₄.

N-Boc 3-(5-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzenamine, CAS: 641571-19-9, stock: 5.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈F₃N₃O₂.

N-Boc-D-3,4-dichlorophenylalanine, CAS: 114873-13-1, stock: 5.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇Cl₂NO₄.

N-Butyl 2-bromo-5-fluorobenzamide, CAS: 951884-19-8, stock: 3.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃BrFNO.

N-Butyl 2-bromobenzamide, CAS: 349403-39-0, stock: 8.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄BrNO.

N-Butyl 3-borono-4-fluorobenzamide, CAS: 874289-50-6, stock: 4.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅BFNO₃.

N-Butyl 3-bromo-4-fluorobenzamide, CAS: 1065074-05-6, stock: 3.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃BrFNO.

N-Butyl 3-Bromobenzamide, CAS: 35390-07-9, stock: 5.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄BrNO.

N-Butyl 4-borono-2-fluorobenzamide, CAS: 874289-17-5, stock: 6.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅BFNO₃.

N-Butyl 4-Bromo-3-methoxybenzamide, CAS: 1065074-09-0, stock: 5.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆BrNO₂.

N-Butyl 4-Bromobenzamide, CAS: 78080-34-9, stock: 7.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄BrNO.

N-Butyl-3-(2-sulfanyl-1H-imidazol-1-yl)benzamide, CAS: 1146290-03-0, stock: 3.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇N₃OS.

N-Butyl-3-hydroxybenzamide, CAS: 15789-00-1, stock: 2.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₂.

N-Butyl-3-nitrobenzamide, CAS: 70001-47-7, stock: 3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O₃.

N-Butyl-4-hydroxybenzamide, CAS: 60696-49-3, stock: 7.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₂.

N-Cyclohexyl 2-bromo-5-fluorobenzamide, CAS: 951884-99-4, stock: 7.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅BrFNO.

N-Cyclohexyl 3-bromo-4-fluorobenzamide, CAS: 1065074-00-1, stock: 3.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅BrFNO.

N-Cyclohexyl 3-bromo-5-nitrobenzamide, CAS: 941294-22-0, stock: 9.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅BrN₂O₃.

N-Cyclohexyl 3-bromobenzamide, CAS: 59507-55-0, stock: 1.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆BrNO.

N-Cyclohexyl 3-fluorobenzamide, CAS: 2267-94-9, stock: 5.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆FNO.

N-Cyclohexyl 4-(Aminomethyl)benzamide, CAS: 172735-66-9, stock: 9.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O.

N-Cyclohexyl 4-borono-2-fluorobenzamide, CAS: 874289-11-9, stock: 4.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇BFNO₃.

N-Cyclohexyl 4-bromo-2-methoxybenzamide, CAS: 1257665-02-3, stock: 6.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈BrNO₂.

N-Cyclohexyl 4-bromo-3-methoxybenzamide, CAS: 1072944-40-1, stock: 4.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈BrNO₂.

N-Cyclohexyl 4-bromo-3-nitrobenzamide, CAS: 849537-85-5, stock: 2.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅BrN₂O₃.

N-Cyclohexyl 4-bromobenzamide, CAS: 223553-87-5, stock: 2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆BrNO.

N-Cyclohexyl 4-Chlorobenzamide, CAS: 57707-20-7, stock: 1.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆NOCl.

N-Cyclohexyl-4-bromo-3-methylbenzamide, CAS: 1020252-80-5, stock: 5.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈BrNO.

N-Cyclohexyl-N-(cyclohexylcarbamoyl)-2-(diphenylphosphino)benzamide, CAS: /, stock: 1.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₇N₂O₂P.

N-Cyclohexyl-N-methyl 2-bromobenzamide, CAS: 349395-89-7, stock: 1.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈BrNO.

N-Cyclohexyl-N-methyl 4-boronobenzamide, CAS: 913835-84-4, stock: 5.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀BNO₃.

N-Cyclopentyl 2-bromo-5-fluorobenzamide, CAS: 951884-13-2, stock: 8.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃BrFNO.

N-Cyclopentyl 2-bromobenzamide, CAS: 326899-55-2, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄BrNO.

N-Cyclopentyl 3-bromo-5-nitrobenzamide, CAS: 941294-18-4, stock: 5.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃BrN₂O₃.

N-Cyclopentyl 4-bromo-3-methylbenzamide, CAS: 1020252-78-1, stock: 9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆BrNO.

N-Cyclopentyl 4-bromobenzamide, CAS: 223557-21-9, stock: 4.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄BrNO.

N-Cyclopentyl-2-hydroxy-n-methylbenzamide, CAS: 1094710-71-0, stock: 3.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₂.

N-Cyclopropyl 2-bromobenzamide, CAS: 88229-18-9, stock: 2.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀BrNO.

N-Cyclopropyl 3-bromo-4-fluorobenzamide, CAS: 639858-63-2, stock: 2.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉BrFNO.

N-Cyclopropyl 3-bromo-5-nitrobenzamide, CAS: 941294-17-3, stock: 5.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉BrN₂O₃.

N-Cyclopropyl 4-(Aminomethyl)benzamide, CAS: 789489-39-0, stock: 1.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O.

N-Cyclopropyl 4-Aminobenzamide, CAS: 38681-77-5, stock: 3.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O.

N-Cyclopropyl 4-borono-2-fluorobenzamide, CAS: 874289-20-0, stock: 7.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁BFNO₃.

N-Cyclopropyl 4-bromo-2-ethoxybenzamide, CAS: 1262011-20-0, stock: 4.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄BrNO₂.

N-Cyclopropyl 4-bromo-2-methoxybenzamide, CAS: 1257665-11-4, stock: 3.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂BrNO₂.

N-Cyclopropyl 4-bromo-3-methoxybenzamide, CAS: 1072944-35-4, stock: 6.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂BrNO₂.

N-Cyclopropyl 4-bromo-3-nitrobenzamide, CAS: 1096842-91-9, stock: 8.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉BrN₂O₃.

N-Cyclopropyl 4-bromobenzamide, CAS: 306745-64-2, stock: 2.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀BrNO.

N-Cyclopropyl 4-fluorobenzamide, CAS: 88229-16-7, stock: 4.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀FNO.

N-Cyclopropyl-2-methyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, CAS: 1351374-48-5, stock: 9.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄BNO₃.

N-cyclopropyl-3,5-difluoro-4-hydrazinylbenzamide, CAS: 1343718-44-4, stock: 9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁N₃OF₂.

N-Cyclopropyl-3-hydroxybenzamide, CAS: 1019466-68-2, stock: 8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₂.

N-Cyclopropyl-3-sulfamoylbenzamide, CAS: 1094453-15-2, stock: 4.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₃S.

N-Cyclopropyl-4-(methylsulfanyl)benzamide, CAS: 1088204-17-4, stock: 1.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NOS.

N-Cyclopropyl-4-(piperidin-3-ylmethoxy)benzamide Hydrochloride, CAS: 1332530-77-4, stock: 7.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂N₂O₂.HCl.

N-Cyclopropyl-4-[(cyclopropylamino)methyl]benzamide, CAS: 1000932-00-2, stock: 8.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₂O.

N-Cyclopropyl-4-[(methylamino)methyl]benzamide Hydrochloride, CAS: 1172976-87-2, stock: 4.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O  •  HCl.

N-Cyclopropyl-4-[6-(2,3-difluoro-4-methoxyphenoxy)-8-[(3,3,3-trifluoropropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide, CAS: 1554458-53-5, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₄F₅N₅O₃.

N-Cyclopropyl-4-{[(furan-2-ylmethyl)amino]methyl}benzamide Hydrochloride, CAS: 1172528-99-2, stock: 5.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₂O₂ • HCl.

N-Desethyl Metoclopramide, CAS: 27260-19-1, stock: 8.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈ClN₃O₂.

N-Desmethyl Imatinib, CAS: 404844-02-6, stock: 2.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₉N₇O.

N-Desmethyl Imatinib Dimesylate, CAS: /, stock: 8.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₉N₇O  • C ₃H₈O₂S.

N-Desmethyl Imatinib Mesylate, CAS: 404844-03-7, stock: 2.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₃N₇O₄S.

N-Desmethyl Itopride Hydrochloride, CAS: 5922-37-2, stock: 5.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₅ClN₂O₄.

N-Diethyl 3-borono-5-chlorobenzamide, CAS: 957120-59-1, stock: 2.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅BClNO₃.

N-Diisopropyl 2-bromobenzamide, CAS: 79839-66-0, stock: 8.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈BrNO.

N-Diisopropyl 4-bromobenzamide, CAS: 79606-46-5, stock: 8.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈BrNO.

N-Dimethyl 3-borono-5-chlorobenzamide, CAS: 957120-57-9, stock: 7.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁BClNO₃.

N-Ethyl 2-bromo-5-fluorobenzamide, CAS: 951884-09-6, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrFNO.

N-Ethyl 2-bromobenzamide, CAS: 80031-02-3, stock: 3.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀BrNO.

N-Ethyl 3-borono-4-fluorobenzamide, CAS: 874289-45-9, stock: 8.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁BFNO₃.

N-Ethyl 3-borono-5-chlorobenzamide, CAS: 957120-49-9, stock: 2.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁BClNO₃.

N-Ethyl 3-bromo-4-fluorobenzamide, CAS: 1065073-98-4, stock: 5.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrFNO.

N-Ethyl 3-bromo-5-nitrobenzamide, CAS: 929000-30-6, stock: 2.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrN₂O₃.

N-Ethyl 3-fluorobenzamide, CAS: 150079-37-1, stock: 8.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀FNO.

N-Ethyl 4-(aminomethyl)benzamide, CAS: 777055-55-7, stock: 7.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O.

N-Ethyl 4-borono-2-fluorobenzamide, CAS: 874289-12-0, stock: 1.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁BFNO₃.

N-Ethyl 4-bromo-2-chlorobenzamide, CAS: 1342639-11-5, stock: 3.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrClNO.

N-Ethyl 4-bromo-2-ethoxybenzamide, CAS: 1245563-10-3, stock: 1.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄BrNO₂.

N-Ethyl 4-bromo-2-methoxybenzamide, CAS: 1245563-19-2, stock: 6.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂BrNO₂.

N-Ethyl 4-bromo-3-methoxybenzamide, CAS: 1072944-41-2, stock: 4.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂BrNO₂.

N-Ethyl 4-bromo-3-methylbenzamide, CAS: 1020252-82-7, stock: 1.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂BrNO.

N-Ethyl 4-bromo-3-nitrobenzamide, CAS: 1096291-52-9, stock: 5.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrN₂O₃.

N-Ethyl 4-bromobenzamide, CAS: 41882-25-1, stock: 7.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀BrNO.

N-Ethyl 4-fluorobenzamide, CAS: 772-18-9, stock: 9.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀FNO.

N-Ethyl-2-fluoro-4-(4-formylphenyl)benzamide, CAS: 1393442-45-9, stock: 2.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄FNO₂.

N-Ethyl-2-hydroxybenzamide, CAS: 4611-42-1, stock: 3.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₂.

N-Ethyl-2-iodobenzamide, CAS: 41882-26-2, stock: 6.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀INO.

N-Ethyl-3-(3-nitrophenyl)benzamide, CAS: 1365272-02-1, stock: 2.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₂O₃.

N-Ethyl-3-(4-formylphenyl)benzamide, CAS: 1393441-87-6, stock: 3.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NO₂.

N-Ethyl-3-(6-methoxypyridin-3-yl)benzamide, CAS: 1375069-32-1, stock: 2.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆N₂O₂.

N-Ethyl-3-hydroxy-N-methylbenzamide, CAS: 1094918-79-2, stock: 9.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂.

N-Ethyl-3-hydroxybenzamide, CAS: 15788-98-4, stock: 6.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₂.

N-Ethyl-3-iodobenzamide, CAS: 113948-06-4, stock: 1.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀INO.

N-Ethyl-3-methyl-4-[(oxan-4-yl)amino]benzamide, CAS: 1182835-67-1, stock: 4.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂O₂.

N-Ethyl-3-nitrobenzamide, CAS: 26819-11-4, stock: 3.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O₃.

N-Ethyl-4-iodobenzamide, CAS: 113948-07-5, stock: 1.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀INO.

N-Ethyl-m-toluamide, CAS: 26819-07-8, stock: 7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO.

N-Ethyl-m-toluamide-15N,13C2, CAS: /, stock: 2.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₂H₁₃¹⁵NO.

N-Ethyl-m-toluamide-d5, CAS: /, stock: 4.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈D₅NO.

N-Formyl Axitinib, CAS: /, stock: 6.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₈N₄O₂S.

N-Hydroxy-3-[1-(phenylthio)methyl-1H-1,2,3-triazol-4-yl]benzamide, CAS: 1316652-41-1, stock: 8.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄N₄O₂S.

N-Hydroxy-7-(4-dimethylaminobenzoyl)aminoheptanamide, CAS: 251456-60-7, stock: 7.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅N₃O₃.

N-Hydroxybenzanilide, CAS: 304-88-1, stock: 4.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁NO₂.

N-Hydroxymethyl Axitinib, CAS: /, stock: 6.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₀N₄O₂S.

N-Isobutyl 2-bromo-5-fluorobenzamide, CAS: 951884-17-6, stock: 8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃BrFNO.

N-Isobutyl 2-bromobenzamide, CAS: 88358-26-3, stock: 4.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄BrNO.

N-Isobutyl 4-(aminomethyl)benzamide, CAS: 926184-95-4, stock: 7.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O.

N-Isobutyl 4-Bromobenzamide, CAS: 161768-66-7, stock: 9.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄NOBr.

N-Isopropyl 2-bromo-5-fluorobenzamide, CAS: 951884-14-3, stock: 3.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁BrFNO.

N-Isopropyl 2-bromobenzamide, CAS: 64141-90-8, stock: 5.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂BrNO.

N-Isopropyl 3-borono-4-fluorobenzamide, CAS: 874289-49-3, stock: 9.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃BFNO₃.

N-Isopropyl 3-bromo-4-fluorobenzamide, CAS: 1065073-97-3, stock: 5.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁BrFNO.

N-Isopropyl 3-bromo-5-nitrobenzamide, CAS: 941294-16-2, stock: 5.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁BrN₂O₃.

N-Isopropyl 3-fluorobenzamide, CAS: 459218-95-2, stock: 4.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂FNO.

N-Isopropyl 4-(aminomethyl)benzamide, CAS: 5072-27-5, stock: 8.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O.

N-Isopropyl 4-borono-2-fluorobenzamide, CAS: 874289-16-4, stock: 9.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃BFNO₃.

N-Isopropyl 4-bromo-2-ethoxybenzamide, CAS: 1261895-31-1, stock: 5.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆BrNO₂.

N-Isopropyl 4-bromo-2-methoxybenzamide, CAS: 1257664-91-7, stock: 8.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄BrNO₂.

N-Isopropyl 4-bromo-3-methoxybenzamide, CAS: 1072944-42-3, stock: 6.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄BrNO₂.

N-Isopropyl 4-bromo-3-methylbenzamide, CAS: 1020252-77-0, stock: 6.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄BrNO.

N-Isopropyl 4-bromobenzamide, CAS: 336182-29-7, stock: 9.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂BrNO.

N-Isopropyl 4-fluorobenzamide, CAS: 70001-45-5, stock: 8.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂FNO.

N-Isopropyl-3-nitrobenzamide, CAS: 50445-53-9, stock: 6.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₃.

N-Isopropyl-4-nitrobenzamide, CAS: 38681-76-4, stock: 1.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₃.

N-Methoxy 3-borono-4-fluorobenzamide, CAS: 874289-58-4, stock: 5.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉BFNO₄.

N-Methoxy 4-borono-2-fluorobenzamide, CAS: 913835-58-2, stock: 4.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉BFNO₄.

N-Methoxy 5-borono-2-fluorobenzamide, CAS: 913835-47-9, stock: 1.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉BFNO₄.

N-Methoxy-N,2,3,5-tetramethylbenzamide, CAS: /, stock: 3.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₂.

N-Methoxy-N-methyl 4-bromo-2-fluorobenzamide, CAS: 801303-33-3, stock: 2.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrFNO₂.

N-Methoxy-N-methyl 5-bromo-2-chlorobenzamide, CAS: 842136-59-8, stock: 5.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrClNO₂.

N-Methoxy-N-methyl-4-(trifluoromethyl)benzamide, CAS: 116332-61-7, stock: 3.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀NO₂F₃.

N-Methoxy-N-methyl-4-chlorobenzamide, CAS: 122334-37-6, stock: 5.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀ClNO₂.

N-Methoxy-N-methyl-4-nitrobenzamide, CAS: 52898-51-8, stock: 3.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O₄.

N-Methoxy-N-methylbenzamide, CAS: 6919-61-5, stock: 7.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₂.

N-Methoxybenzamide, CAS: 2446-51-7, stock: 4.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.

N-Methyl 2-bromobenzamide, CAS: 61436-88-2, stock: 9.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈BrNO.

N-Methyl 3-bromo-4-fluorobenzamide, CAS: 337536-22-8, stock: 9.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇BrFNO.

N-Methyl 3-bromo-5-nitrobenzamide, CAS: 90050-52-5, stock: 9.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇BrN₂O₃.

N-Methyl 3-bromobenzamide, CAS: 49834-22-2, stock: 7.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈BrNO.

N-Methyl 3-fluorobenzamide, CAS: 701-39-3, stock: 3.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈FNO.

N-Methyl 4-Aminobenzamide, CAS: 6274-22-2, stock: 3.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂O.

N-Methyl 4-bromo-2-chlorobenzamide, CAS: 893420-23-0, stock: 5.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇BrClNO.

N-Methyl 4-bromo-2-ethoxybenzamide, CAS: 1245563-16-9, stock: 2.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂BrNO₂.

N-Methyl 4-bromo-3-methoxybenzamide, CAS: 1072944-34-3, stock: 8.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀BrNO₂.

N-Methyl 4-bromo-3-nitrobenzamide, CAS: 1096893-94-5, stock: 6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇BrN₂O₃.

N-Methyl 4-bromobenzamide, CAS: 27466-83-7, stock: 6.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈BrNO.

N-Methyl Amisulpride, CAS: 1391054-22-0, stock: 9.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉N₃O₄S.

N-Methyl Amisulpride-d3, CAS: 1794945-81-5, stock: 2.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆D₃N₃O₄S.

N-Methyl-2-[[3-[(1E)-2-(1-oxopyridinyl)ethenyl]-1-oxido-1H-indazol-6-y-sulfinyl]]benzamide, CAS: /, stock: 4.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈N₄O₄S.

N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]sulfonyl]benzamide, CAS: 1348536-59-3, stock: 1.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈N₄O₃S.

N-Methyl-2-[[3-[(1E)-2-(oxidopyridinyl) ethenyl]-1H-indazol-6-yl-thiol]-benzamide, CAS: /, stock: 6.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈N₄O₂S.

N-Methyl-2-[[3-[(1E)-2-(pyridinyl) ethenyl]-[N-methyl,1H-indazol-6-yl-thiol]]-benzamide, CAS: /, stock: 5.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₀N₄OS.

N-methyl-2-[[3-[(1E)-2-(pyridinyl) ethenyl]-[N-[(5hydroxy methyl furanyl)-hydroxymethyl]-1H-indazol-6-yl-thiol]]-benzamide, CAS: /, stock: 4.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₄N₄O₄S.

N-Methyl-2-[[3-[(1Z)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzamide, CAS: 885126-40-9, stock: 6.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈N₄OS.

N-Methyl-3-(3-nitrophenyl)benzamide, CAS: 1365271-36-8, stock: 4.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂N₂O₃.

N-Methyl-3-nitrobenzamide, CAS: 3400-26-8, stock: 5.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈N₂O₃.

N-Methyl-3-piperidin-4-ylbenzamide, CAS: 1221279-03-3, stock: 3.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O.

N-methyl-4-(sulfamoylmethyl)benzamide, CAS: 1247384-67-3, stock: 4.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₃S.

N-Methyl-4-[(methylamino)methyl]benzamide Hydrochloride, CAS: 1052541-64-6, stock: 5.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O  •  HCl.

N-methyl-N-(2H-1,2,3,4-tetrazol-5-ylmethyl)benzamide, CAS: 1333806-14-6, stock: 4.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁N₅O.

N-Phenethylbenzamide, CAS: 3278-14-6, stock: 5.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO.

N-Phenethylbenzamide-d5, CAS: /, stock: 2.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀D₅NO.

N-Phenyl 3-Fluorobenzamide, CAS: 1629-09-0, stock: 7.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀NOF.

N-Phenyl 4-Bromo-3-methoxybenzamide, CAS: 1072944-33-2, stock: 4.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂NO₂Br.

N-Phenyl 4-Bromo-3-methylbenzamide, CAS: 1020252-81-6, stock: 4.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂NOBr.

N-Phenyl-3-(2-sulfanyl-1H-imidazol-1-yl)benzamide, CAS: 1193387-91-5, stock: 6.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃N₃OS.

N-Propyl 2-Bromobenzamide, CAS: 346695-08-7, stock: 7.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂NOBr.

N-Propyl 3-borono-4-fluorobenzamide, CAS: 874289-48-2, stock: 1.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃BFNO₃.

N-Propyl 3-Bromo-4-fluorobenzamide, CAS: 1065074-04-5, stock: 2.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NOFBr.

N-Propyl 4-Bromo-2-ethoxybenzamide, CAS: 1261956-44-8, stock: 8.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆NO₂Br.

N-Propyl 4-Bromo-3-methoxybenzamide, CAS: 1072944-38-7, stock: 2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄NO₂Br.

N-Propyl 4-Bromo-3-methylbenzamide, CAS: 1020252-79-2, stock: 6.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄NOBr.

N-t-Butyl 2-bromo-5-fluorobenzamide, CAS: 941294-23-1, stock: 7.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃BrFNO.

N-t-Butyl 2-bromobenzamide, CAS: 168265-57-4, stock: 6.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄BrNO.

N-t-Butyl 3-borono-4-fluorobenzamide, CAS: 874289-51-7, stock: 7.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅BFNO₃.

N-t-Butyl 3-bromo-4-methoxybenzamide, CAS: 356550-24-8, stock: 2.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆BrNO₂.

N-t-Butyl 3-bromobenzamide, CAS: 42498-39-5, stock: 2.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄BrNO.

N-t-Butyl 4-borono-2-fluorobenzamide, CAS: 874289-18-6, stock: 2.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅BFNO₃.

N-t-Butyl 4-bromo-2-ethoxybenzamide, CAS: 1261988-52-6, stock: 2.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈BrNO₂.

N-t-butyl 4-bromo-2-methoxybenzamide, CAS: 1257665-14-7, stock: 5.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆BrNO₂.

N-t-Butyl 4-bromo-3-methoxybenzamide, CAS: 1072944-39-8, stock: 3.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆BrNO₂.

N-t-Butyl 4-bromobenzamide, CAS: 42498-38-4, stock: 9.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄BrNO.

N-t-butyl-2-methylbenzamide, CAS: 104847-07-6, stock: 1.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO.

N-t-Butyl-4-fluorobenzamide, CAS: 49834-29-9, stock: 6.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄FNO.

N-tert-butyl-3-cyano-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, CAS: 1333319-51-9, stock: 5.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅BN₂O₃.

N-tert-Butyl-4-(chloromethyl)benzamide, CAS: 111818-35-0, stock: 2.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆NOCl.

N-[(1,2-Dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-3-[ethyl[trans-4-[(2-methoxyethyl)methylamino]cyclohexyl]amino]-2-methyl-5-[3-(4-morpholinyl)-1-propyn-1-yl]-benzamide, CAS: 1598383-40-4, stock: 7.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₅₁N₅O₄.

N-[(1,2-Dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-3-[ethyl[trans-4-[(2-methoxyethyl)methylamino]cyclohexyl]amino]-2-methyl-5-[3-(4-morpholinyl)-1-propyn-1-yl]-benzamide-d8, CAS: /, stock: 2.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₃D₈N₅O₄.

N-[(1s)-1-(Aminocarbonyl)-4-[(2-Chloro-1-Iminoethyl)Amino]Butyl]-Benzamide Hydrochloride, CAS: 1373232-26-8, stock: 1.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉N₄O₂Cl.HCl.

N-[(1S,3S)-2,2-Dimethyl-3-[[5-[(4-phenyl-1-piperazinyl)methyl]-3-isoxazolyl]methyl]cyclobutyl]-benzamide, CAS: 1332755-28-8, stock: 3.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₄N₄O₂.

N-[(2,4-Dimethylphenyl)methyl]-3-methoxybenzamide, CAS: 1221449-50-8, stock: 3.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NO₂.

N-[(2-Fluorophenyl)methyl]-3-(2-sulfanyl-1H-imidazol-1-yl)benzamide, CAS: 1146290-02-9, stock: 3.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄N₃OFS.

N-[(3,5-Dimethylphenyl)carbamothioyl]benzamide, CAS: 117174-79-5, stock: 8.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆N₂OS.

N-[(3-Methoxyphenyl)methyl]-2,4-dimethylbenzamide, CAS: 1097449-03-0, stock: 2.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NO₂.

N-[(3R,4R)-4-[[4-(2-Fluoro-6-hydroxy-3-methoxybenzoyl)benzoyl]amino]hexahydro-1H-azepin-3-yl]-4-hydroxy-3,5-dimethyl-benzamide Hydrochloride, CAS: 602278-07-9, stock: 5.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₃ClFN₃O₆.

N-[(4-Aminophenyl)methyl]-4-(trifluoromethyl)benzamide, CAS: 1176631-77-8, stock: 6.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃N₂OF₃.

N-[(4-Aminophenyl)methyl]-4-bromobenzamide, CAS: 1175834-19-1, stock: 6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃N₂OBr.

N-[(4-Fluorophenyl)methyl]-3-(2-sulfanyl-1H-imidazol-1-yl)benzamide, CAS: 1146290-01-8, stock: 5.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄N₃OFS.

N-[(4-Methylphenyl)methyl]-3-(2-sulfanyl-1H-imidazol-1-yl)benzamide, CAS: 1146289-99-7, stock: 2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇N₃OS.

N-[(5-Methylfuran-2-yl)methyl]-3-(2-sulfanyl-1H-imidazol-1-yl)benzamide, CAS: 1146289-98-6, stock: 9.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅N₃O₂S.

N-[1,2-Bis(4-chlorophenyl)-2-[[(4-chlorophenyl)methylene]amino]ethyl]-4-chloro-benzamide, CAS: 115294-32-1, stock: 2.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₀N₂OCl₄.

N-[1,2-Dihydro-1-[(2R,6S)-6-(hydroxymethyl)-2-morpholinyl]-2-oxo-4-pyrimidinyl]-benzamide, CAS: 125455-77-8, stock: 1.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₄O₄.

N-[1-(2-chloroacetyl)piperidin-4-yl]-2-methylbenzamide, CAS: 1258640-47-9, stock: 5.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉N₂O₂Cl.

N-[1-(2-chloroacetyl)piperidin-4-yl]benzamide, CAS: 1315366-89-2, stock: 3.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇N₂O₂Cl.

N-[1-(2H-1,2,3,4-tetrazol-5-yl)cyclopentyl]benzamide, CAS: 1315366-27-8, stock: 1.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅N₅O.

N-[2,3-Dihydro-1,3-dimethyl-6-[(2R)-2-methyl-1-piperazinyl]-2-oxo-1H-benzimidazol-5-yl]-2-methoxybenzamide, CAS: 1910124-24-1, stock: 5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇N₅O₃.

N-[2-(1-methyl-1H-1,3-benzodiazol-2-yl)propan-2-yl]benzamide, CAS: 1461714-37-3, stock: 1.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉N₃O.

N-[2-(Diethylamino)ethyl]-4-hydroxybenzamide, CAS: 106018-37-5, stock: 7.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O₂.

N-[2-(Morpholin-4-yl)ethyl]-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, CAS: 787591-39-3, stock: 4.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈BNO₄.

N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide, CAS: 155054-42-5, stock: 4.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉IN₂O.

N-[2-Hydroxyethyl]benzamide-3-boronic acid, pinacol ester, CAS: 943911-66-8, stock: 8.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂BNO₄.

N-[2-methyl-1-(2H-1,2,3,4-tetrazol-5-yl)propyl]benzamide, CAS: 1315368-47-8, stock: 3.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅N₅O.

N-[2-methyl-1-(5-methyl-4H-1,2,4-triazol-3-yl)propyl]benzamide, CAS: 1334147-52-2, stock: 8.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₄O.

N-[2-[[3-[[(2’-Fluoro-4-methoxy[1,1’-biphenyl]-3-yl)sulfonyl]amino]phenyl]amino]ethyl]-3-methoxybenzamide, CAS: 1796564-57-2, stock: 8.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₈FN₃O₅S.

N-[3-(1H-Imidazol-1-yl)-5-(trifluoromethyl)phenyl]-4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]Benzamide, CAS: 2119583-26-3, stock: 4.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₀F₃N₇O.